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As community-acquired antibiotic-resistant bacterial infections occur with 
increasing frequency, it is important to identify possible environmental reservoirs for 
these organisms.  My dissertation evaluated the presence of antibiotic-resistant 
bacteria in U.S. wastewater intended for reuse and the related public health 
implications.  My objectives were to: 1) Evaluate wastewater from four U.S. 
wastewater treatment plants (WWTPs) for the presence of methicillin-resistant 
Staphylococcus aureus (MRSA); 2) Evaluate the occurrence of vancomycin-resistant 
enterococci (VRE) at four U.S. WWTPs from which treated wastewater is reused; and 
3) Determine and compare MRSA, methicillin-susceptible S. aureus (MSSA), VRE, 
and vancomcyin-susceptible enterococci (VSE) colonization among American 
reclaimed water spray irrigators and controls.   
  
Between 2009 and 2010, 44 wastewater samples were collected from four 
WWTPs, two in the Mid-Atlantic and two in the Midwest regions of the U.S.  I 
analyzed samples for MRSA and VRE using standard membrane filtration.   For the 
third objective, I collected 94 nasal and dermal swabs from 19 spray irrigators and 24 
controls and analyzed them for MRSA, MSSA, VRE, and VSE.  I confirmed all 
isolates and performed antimicrobial susceptibility testing by microbroth dilution.  
Statistical analyses included two-sample proportion tests and logistic regression. 
MRSA and VRE were detected at all WWTPs.  The percentage of MRSA-
positive samples and concentration of VRE decreased as treatment progressed.  
Neither MRSA nor VRE were identified in tertiary-treated samples, but I identified 
both in an un-chlorinated effluent sample.  No MRSA or VRE were detected in nasal 
or dermal samples from spray irrigators or controls.  MSSA and VSE were detected 
in 26% and 11% of spray irrigators and 29% and 0% of controls, respectively.  The 
odds of MSSA, MDR MSSA, and either MSSA or VSE colonization were not 
significantly different between the spray irrigators and controls.   
My dissertation includes the first reports of MRSA at U.S. WWTPs and VRE 
at WWTPs whose effluent is intended for reuse.  This is also the first U.S. evaluation 
of occupational exposure to antibiotic-resistant bacteria in reclaimed water.  My 
findings provide additional scientific evidence that antibiotic-resistant bacteria can 
survive secondary-treated wastewater and may cause increased risks for infection 
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Chapter 1: Introduction 
A number of challenges currently threaten both the quality and quantity of freshwater 
supplies worldwide, including those of the United States.  As of 2012, 783 million people, 11% 
of the world’s population, lacked access to safe drinking water sources (WHO 2012).  
Unfortunately, access to safe water for drinking and other uses could become even more 
restricted in many areas as drought conditions occur with increasing frequency.  In March 2013, 
nearly 45% of the U.S. was experiencing moderate droughts or worse (severe, extreme, or 
exceptional droughts) (NDMC-UNL 2013).  As demand for freshwater increases, and water 
shortages become more common, reclaimed water (treated wastewater effluent) is increasingly 
being used for activities including irrigation, artificial snow production, and groundwater 
recharge (Levine and Asano 2004).  As of 2011, 2.2 billion gallons per day of reclaimed water, 
or 5-6% of wastewater effluent, were being used across the U.S. for multiple types of activities 
(Miller 2011).   
 
There are many potential benefits associated with reclaimed water use, including reduced 
energy consumption and costs from water treatment (EPA 2012).  However, the possibility of 
exposing individuals who come into contact with reclaimed water to bacterial pathogens, as well 
as the public health implications of this exposure, need to be more fully evaluated.  The primary 
goal of wastewater treatment is not to fully remove harmful contaminants, but to remove and 
degrade organic material (Maier 2009).  Previous studies have analyzed specific microbial 
constituents in wastewater, and found that certain pathogens can survive wastewater treatment, 
including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant 




van Hoof 1984; Harwood et al. 2001; Harwood et al. 2005; Iwane et al. 2001b; Mispagel and 
Gray 2005; Poole et al. 2005; Rose 2007; Schwartz et al. 2003; Volkmann et al. 2004).  If 
MRSA, VRE, and other human pathogens do remain in reclaimed water, this may increase the 
risk of illnesses among humans that are occupationally or recreationally exposed to this 
alternative water source. 
 
Several studies concerning microbial constituents in recycled wastewater were conducted 
in the 1980s and 1990s as part of the Monterey Wastewater Reclamation Study for Agriculture 
(MWRSA) (Burau et al. 1987; Nelson et al. 2003; Sheikh et al. 1998).  These studies all 
concluded that indicator organisms and pathogens are either not present or present at negligible 
levels in reclaimed water, suggesting that reclaimed water can be safely used for irrigation.  
However, the type of wastewater treatment required in California under Title 22—chlorination, 
dual-media filtration, coagulation, and flocculation—is not typical of wastewater treatment 
throughout the U.S., and more closely resembles drinking water treatment than wastewater 
treatment in some cases.  To determine whether reclaimed water is a sustainable option for 
applications across the U.S., wastewater treated using more common treatment processes should 
be evaluated.  To my knowledge, only four peer-reviewed studies examining the microbiology of 
wastewater intended for reuse have been published in the past decade, and all of these papers 
concluded that additional research and monitoring is needed before reclaimed water use 
continues to expand (Al-Bahry et al. 2009; Harwood et al. 2005; Jjemba et al. 2010; Rosario et 
al. 2009).  Clearly, additional data are needed to better understand the presence of bacterial 





A number of organizations and agencies have endorsed the exploration and expansion of 
reclaimed water for non-potable uses (EPA 2012; NRC 2012; WateReuse 2012).  However, 
other groups, including the Navajo Nation in Arizona, have expressed concerns about possible 
health consequences from exposure to reclaimed water (Macmillan 2012).  At this time, no 
federal regulations exist for wastewater reuse, only guidelines, creating a lack of comprehensive 
standards for reclaimed water use in the U.S. (EPA 2012).  In the U.S. Environmental Protection 
Agency (EPA)’s 2012 Guidelines for Water Reuse, EPA specifically emphasizes the need “to 
reduce the potential for AR [antibiotic resistance] proliferation, [therefore] future research should 
target identification of the major source(s) of AR (i.e., raw sewage, biosolids, or treated effluent), 
determine treatment conditions that promote AR development, and characterize the persistence 
of AR in the environment. Ultimately, this knowledge will assist in developing mitigation 
strategies and alleviating environmental and public health concerns” (EPA 2012).   
 
The purpose of this dissertation was to address these calls for additional research 
concerning the presence of antibiotic-resistant bacteria in U.S. wastewater intended for reuse and 
related public health implications.  There were three primary research objectives as part of this 
dissertation: 
1. To evaluate municipal wastewater from four U.S. wastewater treatment plants 
(WWTPs) for the presence of MRSA. 
2. To evaluate the occurrence and concentration of VRE at four U.S. WWTPs from 
which treated wastewater is reused at spray irrigation sites.   
3. To determine and compare MRSA, methicillin-susceptible S. aureus (MSSA), VRE, 




spray irrigation workers and office worker controls in the Mid-Atlantic region of the 
United States. 
 
 These research objectives are addressed in three different manuscripts included in this 
dissertation, and the overall dissertation is organized into six chapters described as follows.  
Chapter 2 provides background information on antibiotic-resistant bacterial infections, MRSA, 
VRE, wastewater treatment in the U.S., and reclaimed water use in the U.S., as well as current 
information about the presence of, and exposure to, pathogens and antibiotic-resistant bacteria in 
wastewater and reclaimed water.  Chapter 3 is a manuscript  titled “Methicillin-Resistant 
Staphylococcus aureus (MRSA) Detected at Four U.S. Wastewater Treatment Plants” published 
in Environmental Health Perspectives in November 2012 (Rosenberg Goldstein et al. 2012) that 
is the first published report of MRSA in U.S. wastewater.  Of note, this manuscript was chosen 
by Environmental Health Perspectives as one of its Science Selections in the November 2012 
issue (“Superbug Hideout: Finding MRSA in U.S. Wastewater Treatment Plants,” 
http://ehp.niehs.nih.gov/120-a437a/).  Chapter 4 is a manuscript titled “Occurrence of 
vancomycin-resistant enterococci at four U.S. wastewater treatment plants” that describes the 
first time VRE was detected in 1) wastewater at four U.S. WWTPs whose effluent is intended for 
reuse and 2) WWTPs located in the Mid-Atlantic region of the U.S.  Chapter 5 is a manuscript 
titled “Occupational exposure to Staphylococcus aureus and Enterococcus spp. among spray 
irrigation workers using reclaimed water” that was submitted for publication in March 2013.  
This paper evaluated the risk for occupational exposure to antibiotic-resistant bacteria, 




the conclusions that can be drawn from this body of research, future directions for research 








Chapter 2: Background 
 
Antibiotic resistance 
Antibiotic resistance is a growing public health concern around the world and in the 
United States.  Antibiotic-resistant bacteria are bacteria that have acquired resistance, or are 
inherently resistant, to antimicrobials that would otherwise limit their growth or kill them.  
Antibiotic-resistant bacteria present a threat to human health because they limit treatment 
options, often cause more serious infections than their antibiotic-susceptible counterparts, and 
are more likely to cause mortality (Drees et al. 2008; Siegel et al. 2006; Zhang et al. 2009).  The 
number of hospitalizations with antibiotic-resistant infections in the United States increased 
approximately 3.6 times between 1997 and 2006 (Mainous et al. 2011).  The increase in 
antibiotic-resistant bacteria and antibiotic-resistant bacterial infections could be the result of a 
number of factors including the overuse and misuse of antibiotics in humans, antibiotic use in 
animal and crop agriculture, antimicrobial substances in personal care products, and the 
incomplete removal of antimicrobials from wastewater treatment plants (WWTPs). 
 
Leading causes of antibiotic-resistant bacterial infections 
Two of the leading causes of antibiotic-resistant bacterial infections are methicillin-
resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) (Mainous 
et al. 2011).  These bacteria cause many infections acquired in hospital settings, and are also 
causing a growing number of infections among individuals who have not come into contact with 






Staphylococcus aureus is a bacterial pathogen associated with a wide range of human 
infections including skin and soft tissue infections, pneumonia, and septicemia (Bassetti et al. 
2009).  S. aureus is found throughout the environment in humans and animals, air, dust, water, 
milk, and food, although humans and animals are the primary reservoirs (FDA 2009).  In 
addition to possessing characteristics that help it survive in the environment, S. aureus also has 
several characteristics that elicit immune responses in the body.   Protein A, located on the 
surface of most strains of S. aureus, selectively binds to the receptors for immunoglobulin (P 
Murray et al. 2002).  Once inside the body, S. aureus is able to survive partially due to its 
production of bound coagulase, a clumping factor that helps the organism bind to tissue surfaces.  
S. aureus is the only species of Staphylococcus to produce this enzyme (P Murray et al. 2002).  
Some strains of S. aureus also produce a highly heat-stable protein toxin, or enterotoxin (FDA 
2009).  It has been estimated that S. aureus is present in the nose, throat, hair, and skin of 50% or 
more of healthy individuals (FDA 2009).  An even greater percentage of healthcare workers, 
hospital patients, and regular needle users are colonized with this bacterium (P Murray et al. 
2002).  According to samples collected in the 2003–2004 National Health and Nutrition 
Examination Survey (NHANES), between 27.2% and 30% of the United States population, or 75 
to 82.9 million individuals, were nasally colonized with S. aureus (Gorwitz et al. 2008).  
Colonization with S. aureus can be either acute or chronic (Chambers 2001; Sanford et al. 1994).  
Colonization with S. aureus is more common among males, non-Hispanic whites and Mexican 
Americans, obese individuals, and individuals under 20 years old (Gorwitz et al. 2008).  In 




(Adcock et al. 1998).  In adults, S. aureus is often found in moist skin folds, in the nasopharynx, 
and gastrointestinal and urogenital tracts (P Murray et al. 2002).  Although S. aureus 
colonization is widespread among humans, most individuals are asymptomatic rather than 
presenting for infection (Chambers 2001).  
MRSA, a particular group of S. aureus that possesses genes conferring resistance to 
penicillinase-stable penicillins (methicillin and oxacillin), was first isolated in 1960 (Bassetti et 
al. 2009).  MRSA infections are most often associated with skin and soft tissues infections (CDC 
2009).  A study by Gorwitz et al. (2008) that found the prevalence of MRSA colonization in the 
general U.S. population is approximately 1.5% based on the 2003-2004 NHANES data (Gorwitz 
et al. 2008).  In 2005, MRSA infections were ultimately responsible for the death of 
approximately 18,650 individuals in the United States (Klevens et al. 2007).     
 
 Mechanisms of action and mechanisms of resistance 
Methicillin, or the more commonly prescribed oxacillin, binds to penicillin binding 
protein (PBP) in the S. aureus cell wall, disrupting synthesis of the peptidoglycan layer, and 
leading to the death of S. aureus (Deurenberg and Stobberingh 2008).  The mecA gene encodes 
for penicillin binding protein 2a (PBP2a) which does not allow methicillin or any β-lactam 
antibiotics to bind (Deurenberg and Stobberingh 2008). 
In addition to being resistant to the penicillin class of antibiotics, MRSA isolates are also 
generally resistant to a greater percentage of other types of antibiotics compared to methicillin-




compared to 36.9% of MSSA isolates recovered from 43 U.S. medical centers included in a 
large-scale study by Richter et al. (2011) were resistant to erythromycin (Richter et al. 2011). 
 
MRSA characterization 
MRSA is often characterized using a number of different techniques including SCCmec 
typing, pvl gene detection, and pulsed field gel electrophoresis (PFGE).  Staphylococcal cassette 
chromosome mec (SCCmec) is a mobile genomic island on which the mecA gene is located 
(Deurenberg and Stobberingh 2008).  SCCmec also contains ccr genes (cassette chromosome 
recombinases) that control integration and excision of SCCmec from the genome (Deurenberg 
and Stobberingh 2008).  There are currently eight SCCmec types that have been identified 
(Center 2013).  Panton Valentine leukocidin (PVL) targets and destroys white blood cells 
(neutrophils), the first line of defense in the human immune system against bacterial infection 
(Center 2013).  PVL kills leukocytes by damaging the cell membrane (Deurenberg and 
Stobberingh 2008).  Based on a large-scale study in the U.S. through NHANES, most MSSA 
isolates do not carry the pvl gene, and pvl gene possession among MRSA isolates depends on the 
MRSA strain type (Tenover et al. 2008).  PFGE is used to define MRSA strain types based on 
banding patterns.  PFGE groups USA100 and USA300 are the most common MRSA strain types 
in the United States (Tenover et al. 2008).  USA100 are typically associated with hospital-
acquired MRSA, whereas USA300 are more commonly associated with community-acquired 





For the past four decades, MRSA infections have been largely associated with hospital 
environments and referred to as hospital-acquired MRSA (HA-MRSA) (Bassetti et al. 2009; 
Gorwitz et al. 2008).  By the end of 1998, the prevalence of MRSA isolates from intensive care 
units was almost 50% and this percentage is expected to increase  (Chambers 2001; Diekema et 
al. 2001).  Most HA-MRSA strains are resistant to several classes of antimicrobials including 
aminoglycosides, erythromycin, clindamycin, and tetracycline (Flynn and Cohen 2008). 
 
Community-acquired MRSA 
In the late 1990s, community-acquired MRSA (CA-MRSA) infections began to appear in 
otherwise healthy people who had no known risk factors for these infections (Bassetti et al. 2009; 
Gorak et al. 1999).  CA-MRSA is associated with skin and soft tissue infections as well as severe 
systemic infections including sepsis and necrotizing pneumonia (Malik et al. 2006).  CA-MRSA 
can be defined by absence of risk factors (exposure to healthcare settings) or by genetic markers.  
CA-MRSA usually possess pvl genes, are SCCmec types IV, V, or VII, are related to strain type 
USA300, and are typically more virulent than HA-MRSA (Deurenberg and Stobberingh 2008).  
The incidence of CA-MRSA has continued to increase in the United States (Klein 2009).  The 
percentage of USA300 MRSA among total MRSA isolates increased over 9% between 2001-
2002 and 2003-2004 (Tenover et al. 2008).  While outbreaks of CA-MRSA have occurred 
among individuals sharing close contact with others in schools, prisons, nursing homes, and 
locker rooms, other possible environmental reservoirs of MRSA have yet to be comprehensively 






VRE are a public health concern because they cause a large percentage of hospital-
acquired infections, increase mortality rates, and can transfer antibiotic resistance genes within 
the genus as well as to other bacteria.  Enterococci are commensal bacteria found in the 
gastrointestinal (GI) tracts of most humans and animals (Fisher and Phillips 2009).  The most 
common species found in human feces are E. faecium and E. faecalis (Fisher and Phillips 2009).  
Twelve percent of hospital-acquired infections in the U.S. are caused by Enterococcus spp. 
(Fisher and Phillips 2009).  Enterococci, including VRE, can cause urinary tract, bloodstream 
(bacteremia), and wound infections, as well as meningitis, and endocarditis (CDC 2008; P 
Murray et al. 2002; Spacek and Vinetz 2009).  VRE was first reported in England in 1988 
(Uttley et al. 1988).  In the United States, the incidence of VRE infections in hospitals doubled 
between 2000 and 2006 (Ramsey and Zilberberg 2009).  VRE infections are associated with 
increased mortality rates (Fisher and Phillips 2009; Ramsey and Zilberberg 2009).  Genes 
conferring resistance to vancomycin are intrinsic in certain species of enterococci (vanC in E. 
casseliflavus, E. flavescens, and E. gallinarum), however the vanA and vanB genes occur on 
moveable plasmids (Fisher and Phillips 2009).   
 
Mechanisms of action and mechanisms of resistance 
Vancomycin, a glycopeptide antibiotic, alters cell wall synthesis by binding to the D-Ala-




crosslinkages (Courvalin 2006).  van genes alter the target site for vancomycin by altering cell 
wall composition from Ala-D-Ala-D to Ala-D-Ala-Lactate which reduces affinity for the 
antibiotic (Fisher and Phillips 2009).   
 
Transfer of resistance genes 
In addition to the transfer of vancomycin resistance genes between strains of enterococci, 
vancomycin resistance can also be transferred from enterococci to other types of bacteria, 
including S. aureus (NIAID 2009; Sievert et al. 2008).  Enterococcus spp. can exchange 
antimicrobial resistance genes with Staphylococcus spp. on plasmids or transposons (Han et al. 
2009).  The Michigan Department of Community Health reported the first clinical isolate of 
vancomycin-resistant S. aureus (VRSA) in 2002 (Sievert et al. 2008).  VRSA is of particular 
concern because of the limited treatment options for this type of infection.  As of 2012, only 13 
clinical cases of VRSA had been confirmed in the United States, but the incidence of VRSA 
infections could continue to rise (CDC 2012).  Hanrahan et al. (2000) found that vancomycin and 
ampicillin resistance genes make up part of the same large, transferable chromosomal element, 
causing resistance to these two antibiotics to often occur in the same microorganisms (Hanrahan 
et al. 2000).  Resistance genes can also be transferred between environmental and clinical 
settings, such as from clinical strains released into wastewater to community strains contained in 
the wastewater (Guardabassi and Dalsgaard 2004).  Because of enterococci’s ability to survive 
for long periods of time in water (18-30 days at room temperature), it could be cycled between 
clinical and environmental settings, and cause re-exposure among human communities (Lleò et 






Community-associated VRE (CA-VRE) (no previous hospital stay reported) has rarely 
been reported in the U.S. (McDonald 1997; Stevenson 2005), however, the introduction of VRE 
into hospital settings from outside environments has been documented in both the U.S. and 
internationally (Anzar et al. 2004; Raja et al. 2005; Stevenson 2005).  A study in Germany in 
1999 found a 0.9% prevalence of VRE among a “healthy” student population, not admitted to a 
hospital for colonization or infection with VRE (Wendt et al. 1999).   The first CA-VRE urinary 
tract infection was reported in Spain in 2004 and the first skin and soft tissue CA-VRE infection 
was reported in Malaysia in 2005 (Anzar et al. 2004; Raja et al. 2005).  In a study by Stevenson 
et al. (2005) of rural U.S. hospitals, 22% of patients with positive VRE cultures had either been 
in the hospital for less than 48 hours or were outpatients, prompting classification as a CA-VRE 
infection (Stevenson 2005).   
 
Possible environmental sources of antibiotic-resistant bacteria 
 As community-acquired antibiotic-resistant bacterial infections continue to occur with 
more frequency, it is increasingly important to identify possible environmental reservoirs for 
these organisms.  Wastewater and reclaimed water have both been identified as possible 
exposure pathways for CA-MRSA and CA-VRE (Börjesson et al. 2009; McDonald 1997; Poole 
et al. 2005; Rosenberg Goldstein et al. 2012).  To better understand the potential for distribution 
of antibiotic-resistant bacteria from wastewater and reclaimed water, it is important to first 
understand how wastewater is treated, current knowledge about pathogens in wastewater, how 






Wastewater Treatment in the United States 
Because wastewater is treated mainly to remove organic solids, microorganisms that pose 
a threat to human health, including antibiotic-resistant bacteria, are not necessarily completely 
removed during wastewater treatment in the United States.  Because antimicrobials and bacteria 
are both present in wastewater, it has been hypothesized that antimicrobial compounds present in 
wastewater could exert selective pressure for resistant bacteria or that resistance genes could be 
transferred in wastewater (Oh et al. 2009; Rosenberg Goldstein et al. 2012).  More than 16,000 
WWTPs in the United States treat approximately 121 billion liters of wastewater per day (EPA 
2013).   
 




Typical wastewater treatment in the United States can be categorized into three main 
steps, primary, secondary, and tertiary treatment (Figure 1) (Maier 2009).  Primary treatment 
consists of the physical removal of large objects from raw sewage.  Primary treatment usually 
includes screening of large objects, grit removal, and sedimentation (EPA 2004a; Maier 2009).  
Secondary treatment is the use of biological processes to remove suspended solids and 
microorganisms from water that has already undergone primary treatment (Maier 2009).  
Secondary treatment is the minimum level of treatment required by the United States 
government through the Clean Water Act (EPA 2004a).  The most common type of secondary 
treatment in the U.S. is the activated sludge process, which uses nitrifying microorganisms and 
increased levels of oxygen to break down suspended organic materials (Maier 2009).  After the 
activated sludge process, the wastewater is slowed in secondary clarifiers to induce die-off in the 
microbial population.  The secondary clarifiers also allow for physical removal of remaining 
organic material with mechanical arms.  The secondary treatment processes can remove as much 
as 90% of organic material from wastewater (EPA 2004a).  Tertiary treatment is any treatment 
beyond secondary treatment, including disinfection and filtration (Maier 2009).  Free chlorine is 
the most common disinfectant used in the tertiary treatment process, but ultraviolet light and 
ozone are also used (EPA 2004a).   
WWTPs in the United States range from less than secondary to tertiary treatment 
facilities.  In 2008, approximately 96.5 million individuals living in the United States were 
serviced by 7,332 secondary, or less than secondary, WWTPs, which account for slightly less 
than half (49.6%) of all municipal WWTPs  in the United States (EPA 2010).  Approximately 
34% of municipal WWTPs go beyond secondary treatment and 15% of WWTPs now produce no 





Pathogens in wastewater  
Bacterial pathogens occur in large quantities in wastewater because they are excreted in 
the feces of colonized individuals.  A study at a Polish WWTP identified 34 species of bacteria 
and 14 species of fungi in incoming wastewater (Prazmo et al. 2003).  Of the bacteria and fungi 
that were identified, 16 of the bacterial species and four of the fungal species had possible 
allergenic and/or immunogenic properties, which could affect individuals exposed to the 
wastewater (Prazmo et al. 2003).  Reduction of enteric microorganisms can vary greatly among 
regions, WWTPs, and treatment steps, and wastewater effluent often still contains detectable 
levels of these microorganisms (Koivunen et al. 2003; Rose 2007).  The number of pathogenic 
microorganisms and percentage of antibiotic-resistant microorganisms can increase at certain 
stages during the wastewater treatment process, most notably in the activated sludge process 
(secondary treatment process) (de Zutter and van Hoof 1984; Emparanza-Knorr and Torrella 
1995; Kayser et al. 1987; Koivunen et al. 2003; LeChevallier et al. 1988).  Prazmo et al. (2003) 
found that the concentration of total microorganisms in wastewater was two to three times 
greater in the primary and secondary treatment steps compared to the final treatment step 
(Prazmo et al. 2003).  
 
Occupational exposure to microbial pathogens among wastewater treatment plant workers 
Based on data from numerous studies, WWTP workers often report higher levels of GI 
and respiratory disease symptoms than other populations, although there is conflicting evidence 




2001; Khuder et al. 1998; Seuri et al. 2005; Thorn and Kerekes 2001).  A review of the literature 
through 2001 by Thorn and Kerekes (2001) found that several studies identified WWTP workers 
as more likely to report GI and respiratory symptoms and more likely to have antibodies against 
hepatitis A (Thorn and Kerekes 2001).  Few of the studies reviewed by Thorn and Kerekes 
(2001) evaluated the risk of bacterial infections among WWTP workers (2001).  Khuder et al. 
(1998) found that a greater proportion of WWTP workers reported gastroenteritis than controls, 
but no specific microbial agents were identified as causing these symptoms (Khuder et al. 1998).  
A Finnish study interested in determining whether the increased risk of diarrheal disease among 
WWTP workers was attributable to Salmonella found that, although more GI symptoms were 
reported by WWTP workers than controls, there was no significant difference in Salmonella 
antibody levels between the two groups (Seuri et al. 2005). 
 
Reclaimed water use in the U.S.  
Human exposure to wastewater is expanding beyond occupational exposure of WWTP 
workers with the increased use of treated wastewater.  Historically, treated wastewater has been 
discharged into surface water bodies, but as freshwater sources are increasingly stressed, the 
planned reuse of treated wastewater is expanding around the world and across the U.S., creating 
many more opportunities for exposure to wastewater occupationally, as well as residentially and 
recreationally (EPA 2012; Miller 2011).  Water supplied through publically-owned distribution 
systems in the U.S. is all treated to drinking water level quality, although this level of treatment 
is not necessary for all uses, such as industrial and landscaping applications.  Using treated 




surface waters and reduces costs associated with treating water to meet drinking water standards 
(EPA 2012).  The federal government and individual states encourage land application of 
wastewater as an alternative to the traditional discharge of wastewater into surface waters (EPA 
2012).  Amendments to the Federal Water Pollution Control Act require that during the planning 
phase for new WWTPs, land application of wastewater be considered as an end use (MDE 
2009).   
Reclaimed water is already being used across the United States for a number of different 
activities.  In 2011, 2.2 billion gallons of reclaimed water were used per day in the United States 
(Miller 2011).  Reclaimed water is used for a number of reasons including, but not limited to: 
replenishing groundwater supplies, water conservation, additional treatment of wastewater, and 
reduced cost (Levine and Asano 2004).  Reclaimed water is used in both non-potable (land 
application), and to a lesser extent, potable (sources for drinking water treatment plants) projects 
(EPA 2012).  Land applications of reclaimed water include low-rate irrigation, overland flow, 
and high-rate infiltration (groundwater recharge) (Maier 2009; Tien 2007).  The choice of reuse 
method usually depends on site-specific conditions, method of wastewater treatment, and 
intended use of reclaimed water (Maier 2009).  There are more than 200 U.S. water reclamation 
facilities that supply water to over 1,600 parks, playgrounds, and schoolyards (Crook 2005).   
At this time, no federal regulations exist for wastewater reuse, only guidelines. 
Regulations are legally enforceable, whereas guidelines are suggestions for use, but cannot be 
enforced (EPA 2012).  EPA’s 2012 Guidelines for Water Reuse provide technical approaches for 
planning and operating reuse facilities, case studies of current reuse applications, and public 
health considerations related to reuse (EPA 2012).  Each state determines whether to develop 




September 2012, 30 states had passed regulations concerning the use of reclaimed water, 15 
states had developed guidelines, and five states had neither regulations nor guidelines (EPA 
2012).   
In the past, secondary (biological) treatment and disinfection were considered standard 
for reusing treated wastewater (EPA 2012).  Currently, many additional advanced treatments 
exist that can be applied to wastewater effluent before reuse such as reverse osmosis or 
membrane filtration (EPA 2012; NRC 2012).  The majority of U.S. water reclamation facilities 
disinfect water before distribution, but not all treated wastewater intended for reuse is distributed 
through formal reclamation facilities (Crook 2005; Rosenberg Goldstein et al. 2012).  Some 
reuse sites are provided with water directly from WWTPs, which supply varying levels of treated 
wastewater (Rosenberg Goldstein et al. 2012).  Some states still allow the use of primary 
(physical removal of solids has taken place) and secondary (biological) treated wastewater, but 
with additional requirements for buffer zones around application sites, as is the case in the State 
of Maryland (Crook 2005; MDE 2009).  However, buffer zones would not reduce occupational 
exposure for individuals applying reclaimed water by hand.  Most states that have reuse 
guidelines or regulations rely on indicator organism monitoring, most commonly total and fecal 
coliforms, to provide information about the microbial quality of reclaimed water (Crook 2005; 
Levine et al. 2008).  However, it has been noted in a number of studies that there is no significant 
correlation between indicator bacteria and most pathogens in reclaimed water (Harwood et al. 




Pathogens in reclaimed water 
Pathogens, including viruses, bacteria, and protozoa, have been detected in reclaimed 
water in previous studies (Brissaud et al. 2008; Harwood et al. 2005; Jjemba et al. 2010; Rose et 
al. 1996).  The studies that have been completed and published provide evidence that human 
pathogens are often present, sometimes at concentrations below recommended levels set by 
national or international health and environmental agencies, although this is not always the case 
(Brissaud et al. 2008; Crook 2005).  A study of pathogen concentrations in reclaimed water 
intended for spray irrigation of landscape areas at a resort in France never detected helminth 
eggs, Salmonella, or enteroviruses in effluent or reclaimed water (Brissaud et al. 2008).  The 
researchers did identify E. coli and enterococci in reclaimed water samples, but at concentrations 
below European Union recommended levels for bathing waters (Brissaud et al. 2008).  Of 
particular importance for public health, in the Brissaud et al. (2008) study Legionella spp. were 
detected in wastewater effluent and storage ponds supplying spray heads at concentrations 
between 2 x 10
5
 – 3 x 10
7
,  however L. pneumophila was either not detected or detected at levels 
below quantification (Brissaud et al. 2008).  In a study by Harwood et al. (2005), enteric viruses, 
Giardia, and infectious Cryoptospordium oocysts, were detected in 31%, 80%, and 70% of 
reclaimed water samples, respectively (Harwood et al. 2005).   
In addition to the ability of some pathogens to survive wastewater treatment, there may 
be regrowth of injured or unculturable bacteria in the reclaimed water distribution system, as 
noted by Jjemba et al. (2010).  Jjemba et al. (2010) found regrowth of indicator and pathogenic 
bacteria in four reclaimed water distribution systems even when the same bacteria had been 
nondetectable, or detected in low quantities, in effluent from WWTPs (Jjemba et al. 2010).  




systems were– Aeromonas, Legionella, and Mycobacterium– all human pathogens (2010).  The 
WHO suggested monitoring reclaimed water used for agriculture and aquaculture for E. coli or 
parasites in guidelines published in 2006 (WHO 2006).  However, testing for a single indicator 
organism in reclaimed water is not enough to determine the risk for the presence of human 
pathogens because there is no significant correlation between indicators organisms and most 
pathogens in this type of water (Harwood et al. 2005; Jjemba et al. 2010; Levine et al. 2008). 
 
Exposure pathways for microbial pathogens originating from reclaimed water 
Inhalation, dermal contact, and accidental ingestion of wastewater-saturated soil have all 
been suggested as possible routes of exposure to pathogens present in reclaimed water 
(Blumenthal et al. 2001; Camann et al. 1983; Camann et al. 1988; Crook 2005; Mara et al. 2007; 
O'Toole et al. 2008).  Because the infective dose for some pathogens is lower for respiratory 
infections than GI infections, it is especially important to consider aersolization of pathogens and 
inhalation as a route of exposure (Crook 2005; Sobsey 1978).  Bacteria and viruses have both 
been detected in aerosols collected at reclaimed water spray irrigation sites (Camann and Moore 
1987; Camann et al. 1988; Crook 2005; Teltsch et al. 1980).  Total coliforms were detected in 
reclaimed water bioaerosols at a spray irrigation reuse site in concentrations ranging from 18-
1,076 CFU/m
3
 (Teltsch et al. 1980).  A study of secondary treated wastewater reused for spray 
irrigation in Texas found fecal coliform levels in air samples downwind from the reuse site that 
were significantly higher than background levels, although longer retention times in reservoirs 




Both bacteria of interest for the three projects described in this dissertation—MRSA and 
VRE— have previously been detected in aerosols from a variety of settings.  Enterococci have 
been isolated from air samples taken from WWTPs (Fracchia et al. 2006; Korzeniewska et al. 
2009).  Enterococci could be breathed in and colonize either the upper respiratory tract, or be 
swallowed and colonize the GI tract.  In a bioaerosol study at a confined swine operation in 
Canada,  Enterococcus spp. were detected in 17 of 18 air samples and in 17 of 35 nasal swabs 
collected from the hog producers (Létourneau et al. 2010).  Eighty-seven percent of the 
enterococci isolated from air samples at the confined swine operation also contained tetracycline- 
resistance genes (Létourneau et al. 2010). 
MSSA and MRSA can be aerosolized from water and have been detected in air samples 
from a number of environments, including WWTPs (Fracchia et al. 2006; Gandara et al. 2006; 
Gibbs et al. 2006; Schulz et al. 2012).  However, no S. aureus was isolated from air samples 
collected at biosolids application sites in the U.S. in a study by Rusin et al. (2003).  Direct, 
dermal contact is the main exposure route for S. aureus, however because S. aureus can become 
airborne, human exposure can also occur through inhalation (Bassetti et al. 2005).   
To reduce exposure to bioaerosols at reclaimed water spray irrigation sites, 
recommendations generally focus on design features such as buffer zones and setbacks from 
areas with unrestricted use (Crook 2005).  However, for spray irrigation workers hand applying 
reclaimed water, these design features would not reduce their contact with reclaimed water and 
its bioaersols.  It has been estimated that about 10% of bioaerosols are actually ingested after 
inhalation (Tanner et al. 2008).  Rose et al. (1996) estimated that 100 mL/day would be the 
maximum amount of reclaimed water an individual would ingest, if exposed to reclaimed water 





Epidemiological evidence for microbial pathogen exposure from reclaimed water use 
Few epidemiological studies have been undertaken to explore exposure to, and health 
risks from, treated wastewater reuse (Crook 2005; Shuval 1991).  No infectious disease 
outbreaks have been linked to exposure to reclaimed water used for landscape irrigation in the 
U.S., however, it is difficult to confirm causes of sporadic illnesses (Crook 2005).  Raw 
consumption of crops irrigated with untreated wastewater has been found to increase the risk of 
parasitic infections and cholera (Feachem 1982; Shuval 1991).  Occupational exposure to raw 
wastewater used for agricultural irrigation has also been associated with increased risk of 
parasitic and cholera infections (Krishnamoorthi et al. 1973; Shuval 1991).  Previous 
epidemiological studies looking at the risk of infections among workers exposed to treated 
wastewater have produced conflicting results (Blumenthal et al. 2001; Durand and Schwebach 
1989; Linnemann et al. 1984; Shuval 1991).  A study by Blumenthal et al. (2001) in Mexican 
agricultural communities found increased odds of parasitic infections from exposure to 
wastewater stored in one reservoir (Blumenthal et al. 2001).  Individuals exposed to wastewater 
stored in a reservoir used for agricultural irrigation had higher odds of infection with Ascaris 
lumbricoides compared to controls (Blumenthal et al. 2001).  Wastewater retention in multiple 
reservoirs for longer periods of time reduced the odds of infection with A. lumbricoides and 
resulting diarrheal disease (Blumenthal et al. 2001).  In contrast to the increased risk of infection 
detected in by Blumenthal et al. (2001), a study by Linnemann et al. (1984) in the United States 
found no significant difference between reported illness or viral antibody levels (polio, 
coxsackie, or echoviruses) between spray irrigation workers exposed to secondary treated 




Linnemann et al. (1984) study relied on a small sample size (35 spray irrigation workers, 41 
controls) and did not evaluate bacterial colonization among the participants, which could have 
underestimated the true public health risks among those exposed to reclaimed water (Linnemann 
et al. 1984).  Durand and Schwebach (1989) found no increased odds of reported GI illness 
among those recreationally exposed to parks irrigated with reclaimed water (Durand and 
Schwebach 1989).  However, they did find that a greater proportion of individuals exposed to 
wet grass conditions reported GI symptoms (Durand and Schwebach 1989).  As part of their 
jobs, reclaimed water spray irrigation workers are routinely working in wet grass conditions.  A 
Texas-based study analyzing the risk of viral infections among individuals residentially exposed 
to secondary treated wastewater reused for agricultural spray irrigation found an increased risk of 
1.5-1.8 compared to those not exposed to reclaimed water (Camann et al. 1988). 
 
Antibiotic-resistant bacteria in wastewater and reclaimed water 
Several studies have identified the presence of antibiotic-resistant bacteria, including 
MRSA and VRE, in wastewater throughout the treatment process (Araujo et al. 2010; Börjesson 
et al. 2009; Garcia et al. 2007; Iwane et al. 2001a; Koivunen et al. 2003; Kotzamanidis et al. 
2009; Nagulapally et al. 2009).  The concentration of antibiotics released into wastewater are 
often high enough to exert selective pressures to favor the proliferation of resistant strains of 
microorganisms (Garcia et al. 2007; Kummerer 2001). The combination of high concentrations 
of microorganisms, nutrients, and antibiotics found in wastewater makes it a favorable 
environment for bacterial growth and horizontal transfer of resistance genes (Garcia, et al., 2007; 




resistant E. coli and Salmonella have been isolated from secondary-treated wastewater effluent in 
Japan and Finland, respectively (Iwane et al. 2001a; Koivunen et al. 2003).   
Previous studies conducted in Sweden have detected MRSA in wastewater, but reported a 
decline in MRSA as wastewater treatment progressed.  Specifically, Börjesson et al. (2009) 
showed that the concentration of MRSA as measured by real-time PCR assays decreased as 




 mecA genes 100 ml
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(Börjesson et al. 2009).   
VRE has also been detected in all wastewater treatment steps, including effluent samples 
(Araujo et al. 2010; Caplin et al. 2008; Kotzamanidis et al. 2009; Morris et al. 2012).  The 
majority of studies assessing the presence of VRE in wastewater have been conducted in Europe 
and found VRE prevalence ranging from 2-52% (Kotzamanidis et al. 2009; Luczkiewicz et al. 
2010; Morris et al. 2012).  To my knowledge, Nagulapally et al. (2009) is the only published 
study to have detected VRE at a U.S. municipal WWTP (Nagulapally et al. 2009).  Nagulapally 
et al. (2009) isolated VRE from influent and secondary clarifier (biologically treated) samples, 
but not from UV-disinfected effluent samples (Nagulapally et al. 2009).  Many previous studies 
have also concluded that VRE concentrations decreased as wastewater treatment progressed; 
however VRE has been detected in effluent including disinfected effluent in Europe 
(Kotzamanidis et al. 2009; Morris et al. 2012; Nagulapally et al. 2009).   
Studies by Harwood et al. (2005) and Jjemba et al. (2010) both identified bacteria in 
reclaimed water, but neither performed antimicrobial susceptibility testing on the bacteria that 




analyzed tertiary treated wastewater used for agricultural irrigation in Israel for the presence of 
antibiotic resistance genes (ARG) detected genes that confer resistance to fluroquinolone, 
sulfonamide, tetracycline, macrolide, lincosamide, and streptogramin antibiotics in these samples 
(Negreanu et al. 2012).  However, the ARG detected by Negreanu et al. (2012) could have been 
from nonviable bacteria.   
 
Unanswered questions about antibiotic-resistant bacteria originating from wastewater and 
reclaimed water 
In summary, antibiotic-resistant bacteria pose a major threat to human health. The high 
number of MRSA and VRE infections inside healthcare settings, and the growing number of 
these infections in community settings are concerning.  It is important to determine if there are 
environment reservoirs for these bacteria that are leading to exposure in community settings.  
MRSA and VRE have both been identified in wastewater in Europe, pointing to a possible 
exposure pathway for these bacteria among WWTP workers and the general population after 
wastewater discharge (Araujo et al. 2010; Börjesson et al. 2009; Garcia et al. 2007; Iwane et al. 
2001a; Koivunen et al. 2003; Kotzamanidis et al. 2009; Nagulapally et al. 2009).  However, to 
my knowledge the presence of MRSA in wastewater has never been evaluated in the U.S. and 
only one study at one Midwest WWTP has analyzed wastewater for VRE in the U.S. 
(Nagulapally et al. 2009).  Also, at a time when wastewater reuse is expanding across the U.S., 
little information still exists about the presence of pathogens and public health risks from 
exposure to reclaimed water.  Although some reports and reviews on the safety of reclaimed 
water have concluded that bacterial pathogens do not pose a risk to human health from reclaimed 




(Crook 2005).  To my knowledge, no previous studies have assessed the presence of viable 
antibiotic-resistant bacteria in reclaimed water.  The three papers included in this dissertation 
seek to evaluate wastewater intended for reuse for important human pathogens and provide more 






Chapter 3: Methicillin-Resistant Staphylococcus aureus (MRSA) 
Detected at Four U.S. Wastewater Treatment Plants 
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AMP  Ampicillin 
AXO  Ceftriaxone 
CA-MRSA Community-acquired methicillin-resistant Staphylococcus aureus 
CIP  Ciprofloxacin 
CLI  Clindamycin 
DAP  Daptomycin 
ERY  Erythromycin 
GAF  Gatifloxacin 
GEN  Gentamicin 




LEVO  Levofloxacin 
LZD  Linezolid 
MIC  Minimal inhibitory concentration 
MRSA  Methicillin-resistant Staphylococcus aureus 
MSSA  Methicillin-susceptible Staphylococcus aureus 
OXA+  Oxacillin+2%NaCl 
PCR  Polymerase chain reaction 
PEN  Penicillin 
PFGE  Pulsed field gel electrophoresis 
PVL  Panton valentine leukocidin toxin 
RIF  Rifampin 
SCCmec Staphylococcal cassette chromosome mec 
STR  Streptomycin 
SXT  Trimethoprim/sulfamethoxazole 
SYN  Quinupristin/dalfopristin 
TET  Tetracycline 
VAN  Vancomycin 






The incidence of community-acquired methicillin-resistant Staphylococcus aureus (CA-
MRSA) infections is increasing in the United States, and it is possible that municipal wastewater 
could be a reservoir of this microorganism. To date, no U.S. studies have evaluated the 
occurrence of MRSA in wastewater. 
 
Objective 
We examined the occurrence of MRSA and methicillin-susceptible S. aureus (MSSA) at 
U.S. wastewater treatment plants. 
 
Methods 
We collected wastewater samples from two Mid-Atlantic and two Midwest wastewater 
treatment plants between October 2009 and October 2010. Samples were analyzed for MRSA 
and MSSA using membrane filtration. Isolates were confirmed using biochemical tests and PCR 
(polymerase chain reaction). Antimicrobial susceptibility testing was performed by Sensititre® 
microbroth dilution. Staphylococcal cassette chromosome mec (SCCmec) typing, Panton-
Valentine leucocidin (PVL) screening, and pulsed field gel electrophoresis (PFGE) were 
performed to further characterize the strains. Data were analyzed by two-sample proportion tests 






We detected MRSA (n=240) and MSSA (n=119) in 22 out of 44 (50%) and 24 out of 44 
(55%) wastewater samples, respectively.  The odds of samples being MRSA-positive decreased 
as treatment progressed: 10 out of 12 (83%) influent samples were MRSA-positive, while only 
one out of 12 (8%) effluent samples was MRSA-positive.  Ninety-three percent and 29% of 
unique MRSA and MSSA isolates were multidrug-resistant, respectively.  SCCmec types II and 
IV, the pvl gene, and USA types 100, 300, and 700 were identified among the MRSA isolates. 
 
Conclusions 
Our findings raise potential public health concerns for wastewater treatment plant 
workers and individuals exposed to reclaimed wastewater.  As reclaimed wastewater use 
accelerates, the risk of exposure to antibiotic-resistant bacteria in treated wastewater deserves 






Staphylococcus aureus is a bacterial pathogen associated with a wide range of human 
infections including skin infections, pneumonia, and septicemia (Bassetti et al. 2009).  Infections 
with this microorganism can be difficult to treat because the strains are often resistant to one or 
more antibiotics including methicillin.  Methicillin-resistant Staphylococcus aureus (MRSA) was 
first isolated in 1960 and for the past four decades MRSA infections have been largely associated 
with hospital environments and referred to as hospital-acquired MRSA (HA-MRSA) (Bassetti et 
al. 2009; Gorwitz et al. 2008).  However, in the late 1990s, community-acquired MRSA (CA-
MRSA) infections began to appear in otherwise healthy people who had no known risk factors 
for these infections (Bassetti et al. 2009; Gorak et al. 1999).  The incidence of CA-MRSA has 
continued to increase in the United States, and while outbreaks of CA-MRSA have occurred 
among individuals sharing close contact with others in schools, prisons, and locker rooms, other 
possible environmental reservoirs of MRSA have yet to be comprehensively explored (Diekema 
et al. 2001).   
 
Identifying environmental reservoirs of MRSA in the community, however, is critical if 
the spread of CA-MRSA infections is to be controlled.  Among other potential environmental 
reservoirs, wastewater has been identified as a possible source of exposure to MRSA in the 
community (Börjesson 2009; Börjesson et al. 2010; Plano et al. 2011).  Colonized humans shed 
MRSA from the nose, feces, and skin; therefore, MRSA can end up in municipal wastewater 
streams (Börjesson 2009; Börjesson et al. 2010; Plano et al. 2011).  Börjesson et al. (2009) 
recently detected MRSA resistance genes in all treatment steps at a Swedish municipal 




study, as well as influent and activated sludge samples in a subsequent study (Börjesson et al., 
2010; Börjesson et al., 2009).  Currently, as water shortages expand, treated municipal 
wastewater is increasingly used for applications including landscape and crop irrigation, 
groundwater recharge, and snowmaking (Levine and Asano 2004; Tonkovic and Jeffcoat 2002).  
During these activities, individuals applying, using, or coming in contact with reclaimed 
wastewater could potentially be exposed to MRSA and other bacteria that may remain in treated 
wastewater (Iwane et al. 2001b). 
   
However, to our knowledge, no studies have demonstrated the occurrence of MRSA in 
wastewater in the United States.  In this study, we evaluated the occurrence of MRSA and 
methicillin-susceptible Staphylococcus aureus (MSSA) at four wastewater treatment plants 
(WWTPs) located in two different regions of the United States: the Mid-Atlantic and the 
Midwest.  To further assess the MRSA strains, isolates were characterized by staphylococcal 
cassette chromosome mec (SCCmec) typing and pulsed field gel electrophoresis (PFGE), and 
screened for Panton-Valentine leucocidin (PVL)—an exotoxin often associated with virulent 





Materials and methods 
Study sites 
Four WWTPs were included in this study – two in the Mid-Atlantic and two in the 
Midwest.  The treatment steps and sampling locations at each of the treatment plants are 
illustrated in Figure 1.  
Mid-Atlantic WWTP1 (Figure 1a) is a tertiary WWTP in an urban area that processes 
681,390 cubic meters per day (m
3
/d) of wastewater with a peak capacity of 1.51 million m
3
/d.  
Mid-Atlantic WWTP2 (Figure 1b) is a tertiary WWTP in a suburban area that processes 7,570 
m
3
/d of wastewater with a peak capacity of 45,425 m
3
/d.  Tertiary wastewater treatment includes 
primary treatment (physical removal of solids), secondary treatment (biological treatment), and 
additional treatment that can include, but is not limited to, chlorination, UV radiation, or 
filtration.  The incoming wastewater at both Mid-Atlantic plants includes domestic and hospital 
wastewater, and effluent from both Mid-Atlantic plants is piped to landscaping sites for reuse in 
spray irrigation. 
Midwest WWTP1 (Figure 1c) is a tertiary WWTP in a rural area that processes 1,363 
m
3
/d of wastewater with a peak capacity of 10,978 m
3
/d.  The incoming water includes domestic 
wastewater and agriculturally influenced stormwater. Seasonal chlorination occurs in June, July 
and August and chlorinated effluent is piped to a landscaping site for reuse in spray irrigation.  
Midwest WWTP2 (Figure 1d) is a secondary WWTP (with no on-site disinfection) in a rural area 
that processes 1,439 m
3
/d with a peak capacity of 7,571 m
3
/d.  Secondary wastewater treatment 
includes only primary treatment (physical removal of solids) and secondary treatment (biological 




food production facility, and agriculturally influenced stormwater.  Unchlorinated effluent is 
piped to an agricultural site for crop irrigation. 
Sample collection 
A total of 44 grab samples were collected between October 2009 and October 2010: 12 
samples from Mid-Atlantic WWTP1; 8 samples from Mid-Atlantic WWTP2; 12 samples from 
Midwest WWTP1; and 12 samples from Midwest WWTP2.  The timing of each sampling event 
was determined by the availability and schedule of the WWTP operators.  The sampling time 
schedule and specific sampling locations for each plant are indicated in Tables 1 and 2 and 
Figure 1.  Samples were collected in 1L sterile polyethylene Nalgene® Wide Mouth 
Environmental Sample Bottles (Nalgene, Lima, OH), labeled, and transported to the laboratory at 
4 °C.  All samples were processed within 24 h. 
Isolation 
Membrane filtration was used to recover S. aureus and MRSA from wastewater samples. 
Briefly, 300 ml of each sample were vacuum filtered through a 0.45 µm, 47 mm mixed cellulose 
ester filter (Millipore, Billerica, MA).  Filters were then enriched in 40 ml of m Staphylococcus 
broth (Becton, Dickinson and Company, Franklin Lakes, NJ), vortexed, and incubated at 37 °C 
for 24 h.  A 10 µl loopful of each enrichment was then plated in duplicate on MRSASelect (Bio-
Rad Laboratories, Hercules, CA) and Baird Parker agar (Becton, Dickinson and Company) for 
the isolation of MRSA and total S. aureus, respectively.  Plates were incubated at 37 °C for 24 h.  
Resulting black colonies with halos on Baird Parker and hot pink colonies on MRSASelect were 
considered presumptive S. aureus and MRSA, respectively.  These colonies were purified on 
Brain Heart Infusion (BHI) agar (Becton, Dickinson and Company) and archived in Brucella 




was used as a positive control and phosphate buffered saline was used as a negative control 
throughout the isolation process for quality control and quality assurance. 
Identification 
S. aureus and MRSA were confirmed using the Gram stain, the coagulase test (Becton, 
Dickinson and Company), the catalase test, and PCR.  DNA extraction was carried out using the 
MoBio UltraClean® Microbial DNA Isolation Kit (Mo Bio Laboratories, Carlsbad, CA) per the 
manufacturer’s recommendations.  For confirmation of S. aureus, PCR amplification of the S. 
aureus-specific nuc gene was carried out using the NUC1 and NUC2 primers (Fang and Hedin, 
2003).  For MRSA differentiation, PCR amplification targeting the mecA gene, which encodes 
for methicillin resistance, was performed using the MECA1 and MECA2 primers, both as 
previously described by Fang and Hedin (Brakstad et al. 1992; Fang and Hedin 2003; Smyth et 
al. 2001)  The method was modified by including an internal control, using primers targeting the 
16S rDNA genes, in a multiplex PCR assay (Edwards et al. 1989).  PCR amplification consisted 
of an initial denaturing step of 95 °C for 3 min, followed by 34 cycles of denaturing at 94 °C for 
30 s, annealing at 55 °C for 30 s, and extension at 72 °C for 30 s, with a final extension at 72 °C 
for 5 min. 
Antimicrobial susceptibility testing 
Antimicrobial susceptibility testing was performed using the Sensititre® microbroth 
dilution system in accordance with the manufacturer’s instructions on all PCR-confirmed MRSA 
(n=240) and MSSA (n=119) isolates (Trek Diagnostic Systems Inc., Cleveland, OH).  Overnight 
cultures were transferred to sterile demineralized water (Trek Diagnostic Systems, Westlake, 
OH) to achieve a 0.5 McFarland standard.  Then, 30 µL of each suspension was transferred to 




µL of the broth solution was then dispensed into GPN3F minimal inhibitory concentration (MIC) 
plates (Trek Diagnostic Systems Inc.) with the following antibiotics (range of concentrations in 
µg/ml): erythromycin (ERY; 0.25-4), clindamycin (CLI; 0.12-2), quinupristin/dalfopristin (SYN; 
0.12-4), daptomycin (DAP; 0.25-8), vancomycin (VAN; 1-128), tetracycline (TET; 2-16), 
ampicillin (AMP; 0.12-16), gentamicin (GEN; 2-16, 500), levofloxacin (LEVO; 0.25-8), 
linezolid (LZD; 0.5-8), ceftriaxone (AXO; 8-64), streptomycin (STR; 1000), penicillin (PEN; 
0.06-8), rifampin (RIF; 0.5-4), gatifloxacin (GAT; 1-8), ciprofloxacin (CIP; 0.5-2), 
trimethoprim/sulfamethoxazole (SXT; 1/19-4/76), and oxacillin+2%NaCl (OXA+; 0.25-8).  
Enterococcus faecalis ATCC 29212 and S.
 
aureus ATCC 29213 were
 
used as quality control 
strains.  MICs were recorded as the lowest concentration of an antimicrobial that completely 
inhibited bacterial growth (CLSI 2010).  Resistance breakpoints published by the Clinical and 
Laboratory Standards Institute were used (CLSI 2010).  Multidrug resistance (MDR) was 
defined as resistance to two or more classes of antibiotics. 
SCCmec typing 
A multiplex PCR assay developed by Milheiriço et al. (2007) was used to characterize 
the MRSA isolates (n=240) by SCCmec type (Milheiriço et al. 2007; Oliveira and de Lencastre 
2002).  SCCmec strains COL (type I), BK2464 (type II), ANS46 (type III), MW2 (type IVa), 
HAR22 (type IVh), and HDE288 (type VI) were used as positive controls for SCCmec typing. 
 
PVL screening 
All MRSA isolates, confirmed by possession of the nuc and mecA genes by PCR and an 
identifiable SCCmec type (n=236), were screened for PVL by PCR of the pvl gene according to 





Pulsed field gel electrophoresis 
PFGE was performed on a subset of 22 MRSA isolates.  To ensure a diverse, 
representative subset, isolates were selected using the following criteria: treatment plant, 
sampling date, SCCmec type, and each sampling location that had a positive sample.  PFGE was 
based on the Centers for Disease Control and Prevention (CDC) Laboratory Protocol for 
Molecular Typing of S. aureus by PFGE (www.cdc.gov/pulsenet).  SmaI (Promega, Madison, 
WI) was used to digest genomic DNA.  Digested samples were run in 1% SeaKem® Gold 
agarose (Cambrex Bio Science Rockland, Inc., Rockland, ME) gels in 0.5X TBE using a CHEF 
Mapper (Bio-Rad) for 18.5-19 h at the following settings: voltage of 200 V, temperature of 14° 
C, and initial and final switch of 5 and 40 seconds.  Cluster analysis was performed using 
BioNumerics software v5.10 (Applied Maths Scientific Software Development, Saint-Martens-
Latem, Belgium) using Dice coefficient and the unweighted pair-group method (UPGMA).  
Optimization settings for dendrograms were 1.0% with a position tolerance of 0.95%.  Based on 
the similarity of the control strains, isolates were considered clones if similarity was ≥ 88%.  
Salmonella serotype Braenderup strain H9812 was used as the standard.  
 
Statistical analyses 
 Descriptive statistics were reported for the percentages of wastewater samples that were 
positive for MRSA and MSSA by WWTP.  Statistical analyses of antibiotic resistance data were 
limited to MRSA (n=84) and MSSA (n=58) isolates expressing unique phenotypic profiles to 
reduce bias that could be introduced by including clones, since PFGE was not performed on all 




with respect to the percent resistance of each group of isolates to each of the 18 tested antibiotics.  
ANOVA was then used to compare the average numbers of antibiotics against which MRSA and 
MSSA isolates were resistant.  In all cases, p-values of ≤ 0.05 were defined as statistically 
significant.  All statistical analyses were performed using Stata/IC 10 (StatCorp LP, College 






Occurrence of MRSA 
MRSA were detected at all WWTPs in this study.  The distribution of MRSA-positive 
samples differed by WWTP, sampling date, and sampling location (Table 1).  Across all 
treatment plants sampled, 50% (22/44) of wastewater samples were positive for MRSA:  60% 
(12/20) of samples from Mid-Atlantic WWTPs; and 42% (10/24) of samples from Midwest 
WWTPs.  Eighty-three percent (10/12) of influent samples from all WWTPs were MRSA-
positive; 100% (5/5) from Mid-Atlantic WWTPs and 71% (5/7) from Midwest WWTPs.  No 
MRSA were detected in any tertiary-treated (chlorinated) effluent samples (Table 1).  However, 
MRSA was detected in one effluent sample from Midwest WWTP1 in October 2010 when 
chlorination was not taking place.  Overall, Midwest WWTP2 had the lowest percentage of 
MRSA-positive wastewater samples with MSRA detected only in the influent (Table 1).  This 
plant is the only WWTP in the study that does not use an activated sludge reactor step; instead, it 
uses a system of lagoons for biological treatment.   
 
Occurrence of MSSA 
MSSA were also detected at all WWTPs in this study.  The distribution of MSSA-
positive samples differed by WWTP, sampling date, and sampling location (Table 2).  Across all 
treatment plants sampled, 55% (24/44) of wastewater samples were positive for MSSA: 60% 
(12/20) of samples from Mid-Atlantic WWTPs; and 50% (12/24) of samples from Midwest 
WWTPs.  Eighty-three percent (10/12) of influent samples from all WWTPs were MSSA-




detected in tertiary-treated (chlorinated) effluent samples (Table 2).  However, MSSA was 
detected in two effluent samples from Midwest WWTP1 in September and October 2010 when 
chlorination was not taking place.  Overall, Midwest WWTP2 had the lowest percentage of 
MSSA-positive wastewater samples of all four WWTPs with MSSA detected only in the 
influent.   
 
Antibiotic resistance patterns 
In total, 240 MRSA isolates were isolated from all WWTPs.  However, as noted above, 
the statistical analyses concerning antibiotic resistance patterns among these isolates were 
limited to those that could be confirmed as unique (n=84) using phenotypic analyses, since 
PFGE was not performed on all isolates.  The unique MRSA isolates had a median oxacillin 
MIC of ≥16 µg/ml (range, 4 to ≥16 µg/ml) and expressed resistance to several antibiotics 
approved by the U.S. Food and Drug Administration for treating MRSA infections, including 
TET, CIP, LEVO, GAT, and CLI, as well as LZD and DAP (Figure 2) which are important 
alternatives to older antibiotics for treating severe MRSA infections (Johnson and Decker 2008).   
 
Antimicrobial resistance patterns among unique MRSA isolates varied by WWTP and 
sampling location (Figure 2).  In general, at both Mid-Atlantic WWTPs and Midwest WWTP1, 
the percentage of isolates resistant to individual antibiotics increased or stayed the same as 
treatment progressed (Figures 2a-2c).  At Midwest WWTP2, only influent samples were positive 






In total, 119 MSSA isolates were isolated from all WWTPs.  Similar to our statistical 
analyses of MRSA isolates, our analyses of antimicrobial resistance patterns among MSSA 
isolates were limited to those isolates that could be confirmed as unique (n=58) using phenotypic 
analyses.  Antimicrobial resistance patterns among unique MSSA isolates also varied by WWTP 
(Figure 3).  The percentages of ERY-, AMP- and PEN-resistant unique MSSA isolates at Mid-
Atlantic WWTP1 increased as treatment progressed, whereas the percentages of isolates resistant 
to the fluoroquinolones (LEVO, CIP, and GAT) decreased from influent to activated sludge 
reactor samples (Figure 3a).  At Mid-Atlantic WWTP2, the percentages of ERY-, AMP-, PEN- 
and GAT-resistant MSSA isolates increased from influent to activated sludge reactor samples 
(Figure 3b).  Similarly, among Midwest WWTP1 and Midwest WWTP2 MSSA, resistance to 
AMP and PEN increased as treatment progressed (Figure 3c and 3d). 
 
In terms of percent resistance among the groups of isolates, a greater percentage of 
MRSA isolates compared to MSSA isolates were resistant to the following 14 antibiotics: ERY, 
CLI, STR, SYN, DAP, TET, AMP, RIF, LEVO, PEN, CIP, AXO, GAT, and OXA+ (Table 3).   
MRSA isolates were also resistant to more antimicrobials (on average 6.94) than MSSA isolates 
(on average 2.26) (p < 0.001). 
 
Multi-drug resistance 
Ninety-three percent (78/84) of phenotypically unique MRSA isolates from all WWTPs 
were MDR, while 29% (17/58) of unique MSSA isolates from all WWTPs were MDR.  The 
summary of percent MDR MRSA and MSSA by sampling location (across all plants) is shown 






SCCmec types II and IV were identified among the MRSA isolates (Table 4).  Overall, 
83% (199/240) of the MRSA isolates were type IV and 15% (37/240) were type II.  For all 
WWTPs, except Mid-Atlantic WWTP1, only one SCCmec type was identified at each plant 
(Table 4).  Four isolates (2%) displayed resistance to oxacillin in antimicrobial susceptibility 
testing, but did not have the mecA band in the Fang and Hedin PCR multiplex or the mecA band 
in the SCCmec PCR multiplex. 
 
PVL screening 
Among our total MRSA isolates where SCCmec type could be confirmed, 68% (161/236) 
were positive for the pvl gene: 72% at Mid-Atlantic WWTP1, 75% at Mid-Atlantic WWTP2, 
83% at Midwest WWTP1 and 0% at Midwest WWTP2 (Table 4). 
 
PFGE 
Clusters based on > 88% similarity resulted in 12 unique types among our subset of 22 
isolates, suggesting a heterogeneous population among MRSA from U.S. WWTPs (Figure 5).  
Three different USA types, 100, 300, and 700, were identified.  Nine isolates did not match any 






MRSA and MSSA occurrence in U.S. wastewater 
Although MRSA has been identified in WWTPs in Sweden (Börjesson et al. 2009; 
Börjesson et al. 2010), to our knowledge, this is the first report of the detection of MRSA at 
municipal wastewater treatment plants in the United States.  Fifty percent of total wastewater 
samples were positive for MRSA, while 55% of total samples were positive for MSSA.  Yet, the 
odds of samples being MRSA-positive decreased as treatment progressed.  For example, 10 out 
of 12 (83%) influent samples were MRSA-positive, while only one out of 12 (8%) effluent 
samples was MRSA-positive (Table 1).  Based on these findings, wastewater treatment seems to 
reduce the number of MRSA and MSSA isolates released in effluent.  However, the few isolates 
that do survive in effluent might be more likely to be multidrug resistant and virulent isolates.    
Previous studies conducted in Sweden have also reported a decline in MRSA as 
wastewater treatment progressed.  Specifically, Börjesson et al. (2009) showed that the 





 mecA genes 100 ml
-1
 from inlet to outlet, except for a peak in 
activated sludge reactor samples of 5x10
5
 mecA genes 100 ml
-1 
(Börjesson et al. 2009).  Based on 
these findings, we might also expect to see an overall decrease in MRSA concentrations 
throughout the wastewater treatment process in the U.S., except for perhaps a peak in activated 
sludge.  It is also interesting to note that at Midwest WWTP2, the only WWTP in the study that 
does not employ an activated sludge step, MRSA was detected only in the influent.  The lack of 
MRSA detected beyond influent at Midwest WWTP2 could be due to the effectiveness of an 





Cycling of MRSA between humans and the environment 
Our findings also provide evidence that municipal wastewater could serve as a medium 
for the cycling of CA-MRSA strains between humans and the environment.  MRSA has been 




 CFU/g of fecal material (Wada et al. 2010).  PVL- 
positive strains, SCCmec type IV, and USA 300, all of which characterize the majority of the 
MRSA isolated from wastewater in this study, have traditionally been associated with CA-
MRSA (Gorwitz et al. 2008; Seybold et al. 2006).  The high prevalence of PVL-positive CA-
MRSA in the U.S. population as compared to other countries could explain the high percentage 
of PVL-positive MRSA isolates in wastewater in this study (Seybold et al., 2006; Tristan et al., 
2007).  The association of PVL-positive MRSA and CA-MRSA with skin infections could also 
explain the occurrence of PVL-positive MRSA isolates in wastewater samples in this study, as 
MRSA could be shed in showers at concentrations of approximately 1.4 x 10
4
 – 1.0 x 10
5
 
CFU/person (Lina et al. 1999).  The large cluster of MRSA isolates recovered in this study that 
were PVL-positive and showed similarity to USA 300 is concerning, as USA 300 strains—which 
are typically resistant to erythromycin and β-lactam antibiotics—and the pvl gene are associated 
with increased virulence, severe bloodstream infections, and necrotizing pneumonia (Gorwitz et 
al. 2008; Lina et al. 1999). 
Moreover, the abundance of SCCmec type IV among the recovered MRSA isolates could 
be indicative of superior survival characteristics, namely the lower energy cost of SCCmec type 
IV carriage (Börjesson et al. 2010).  SCCmec type IV strains recovered in this study appeared to 
persist longer in the wastewater treatment process than type II strains.  However, this 




Atlantic WWTP1) and a previous study found that SCCmec type was not significantly associated 
with MRSA survival (Levin-Edens et al. 2011).  
Four isolates that did not have the mecA band in SCCmec typing but were found to be 
oxacillin-resistant through antimicrobial susceptibility testing could have the novel mecA 
homologue, MRSA-LGA 251, as identified by García-Álvarez et al. (García-Álvarez et al. 
2011).  Interestingly, three of these four isolates were from Midwest WWTP1, which is 
surrounded by animal production facilities.  García-Álvarez detected the novel mecA homologue 
in bovine MRSA, although the original source of MRSA-LGA 251 is still under investigation 
(García-Álvarez et al. 2011).  Because traditional mecA primers do not detect this homologue, 
there could be an even greater number of wastewater samples containing MRSA than was 
detected in this study (García-Álvarez et al. 2011).  However, it was beyond the scope of the 
current study to further assess the wastewater samples for the presence of MRSA-LGA 251.  
 
Public health implications 
Our findings raise potential public health concerns for wastewater treatment plant 
workers and individuals exposed to reclaimed wastewater. Wastewater treatment plant workers 
could potentially be exposed to MRSA and MSSA through several exposure pathways, including 
dermal, and inhalation exposures.  However, very few studies have evaluated microbial 
exposures among wastewater workers.  Mulloy et al. (2001) published a review article 
summarizing findings of exposures to Leptospira, Hepatitis A, bacterial enterotoxins and 
endotoxins among WWTP workers (Mulloy 2001).  Yet, to our knowledge, no studies have 




handwashing and the use of gloves among WWTP workers could reduce the potential risks 
associated with possible MRSA exposures. 
Beyond wastewater workers, individuals who are exposed to reclaimed secondary 
wastewater, including spray irrigators and people living near spray irrigation sites, could be 
potentially exposed to MRSA and MSSA.  No federal regulations exist for wastewater reuse 
from either secondary or tertiary facilities, although EPA has issued water reuse guidelines (EPA 
2004b).  States determine whether to develop regulations or guidelines to oversee the use of 
reclaimed wastewater within their boundaries, and most state guidelines allow secondary effluent 
to be used for certain reuse applications, including spray irrigation of golf courses, public parks, 
and agricultural areas (EPA 2004b).  In this study, we detected MRSA and MSSA in 
unchlorinated effluent from Midwest WWTP1, a WWTP with only seasonal chlorination (that 
could be defined as a secondary treatment plant during periods where chlorine is not applied).  
Our findings suggest that implementing tertiary treatments for wastewater that is intended for 
reuse applications could reduce the potential risk of MRSA exposures among individuals who 
are working on or living by properties sprayed with reclaimed wastewater.   
 
Limitations 
There are some notable limitations of this study.  The number and timing of sampling 
events and samples collected at each WWTP was not the same due to access issues at some of 
the plants.  Also, enriching the samples preempted our ability to report concentrations of MRSA 
and MSSA in wastewater.  Meanwhile, since PFGE was performed on a representative subset of 
all MRSA isolates, the true heterogeneity of the MRSA isolates contained in the wastewater 




small number of clonal strains, so the likelihood of isolating MRSA with phenotypic and genetic 
similarities during our isolation procedure was high (Enright et al. 2002; Fang and Hedin 2003; 
Oliveira et al. 2002).  However, the goal of this study was to evaluate the occurrence of MRSA 
at WWTPs in the U.S. and even if clones were selected, the findings concerning the presence and 






To our knowledge, our study is the first to demonstrate the occurrence of MRSA in U.S. 
municipal wastewater.  While tertiary wastewater treatment may effectively reduce MRSA in 
wastewater, secondary-treated wastewater (unchlorinated) could be a potential source of 
exposure to these bacteria in occupational settings and reuse applications.  As reclaimed 
wastewater use accelerates, the risk of antibiotic-resistant bacterial infections from exposure to 
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Table 1: Distribution of methicillin-resistant Staphylococcus aureus positive wastewater samples at all WWTPs, sampling events and sampling 
locations. 




(total # of 
samples 
collected) 
Mid-Atlantic WWTP 1 
(n=12) 
Mid-Atlantic 
WWTP 2 (n=8) 












































− − − − − Neg Pos Pos − − − − 2/3(67) 
Cell B (n=4) 
 
− − − − − − − − Neg Neg Neg Neg 0/4(0) 
Secondary 
clarifier      
(n=8) 
Neg Pos Pos Neg Neg Pos Neg Pos − − − − 4/8(50) 
Effluent 
(n=12) 
Neg Neg Neg Neg Neg Neg Neg Pos
a 


































Pos = positive sample 
Neg = negative sample 
WWTP = wastewater treatment plant 
a










Table 2: Distribution of methicillin-susceptible Staphylococcus aureus positive wastewater samples at all WWTPs, sampling events and sampling 
locations. 




(total # of 
samples 
collected) 
Mid-Atlantic WWTP 1 
(n=12) 
Mid-Atlantic 
WWTP 2 (n=8) 













































− − − − − − − − Pos Neg Neg Neg 1/4(25) 
Secondary 
clarifier      
(n=8) 
 
Neg Pos Pos Neg Neg Pos Neg Pos − − − − 4/8(50) 
Effluent 
(n=12) 














Pos = positive sample 
Neg = negative sample 
WWTP = wastewater treatment plant 
a







 Table 3: Differences in percentage of MRSA and MSSA isolates resistant to each tested 
antibiotic, compared using two-sample tests of proportions. 
 
                                                    Percentage of Resistant Isolates 
Antibiotic MRSA MSSA 
  p-value 
(one-sided) 
Erythromycin 82.14% (69/84) 28.57% (16/56) <0.0001 
Clindamycin 27.38% (23/84) 1.72% (1/58) <0.0001 
Gentamicin 10.84% (9/83) 3.45% (2/58) 0.0537 
Streptomycin 4.76% (4/84) 0% (0/58) 0.0459 
Quinupristin/dalfopristin 7.14% (6/84) 0% (0/58) 0.0188 
Daptomycin 16.67% (14/84) 0% (0/58) 0.0005 
Vancomycin 0% (0/83) 0% (0/57) - 
Tetracycline 14.29% (12/84) 0% (0/58) 0.0013 
Ampicillin 98.81% (83/84) 68.97% (40/58) <0.0001 
Rifampicin 9.76% (8/82) 0% (0/58) 0.0071 
Levofloxacin 63.41% (52/82) 15.79% (9/57) <0.0001 
Linezolid 5.95% (5/84) 3.45% (2/58) 0.2494 
Penicillin 98.81% (83/84) 73.21% (41/56) <0.0001 
Ciprofloxacin 63.10% (53/84) 15.79% (9/57) <0.0001 
Trimethoprim/ 
sulfamethoxazole 
2.38% (2/84) 0% (0/58) 
  0.1184 
Ceftriaxone 30.49% (25/82) 0% (0/58) <0.0001 
Gatifloxacin 62.65% (52/83) 18.97% (11/58) <0.0001 










Table 4: Number (%) of MRSA isolates recovered from wastewater by SCCmec type and by 
possession of the pvl gene
a
 
      
Sampling Location SCCmec Type PVL +
b
  
  Type II Type IV No mecA   
Mid-Atlantic 1 (n=100)  
Influent (n=40) 0(0) 40(100) 0(0) 28(70)  
Activated sludge reactor       
(n=40) 13(33) 27(68) 0(0) 25(63)  
Secondary clarifier  
(n=20) 0(0) 19(95) 1(5) 18(95)  
Effluent (n=0) 0(0) 0(0) 0(0) 0(0)  
Total (n=100) 13(13) 86(86) 1(1) 71(72)  
Mid-Atlantic 2 (n=47)  
Influent (n=20) 0(0) 20(100) 0(0) 9(45)  
Activated sludge reactor     
(n=27) 0(0) 27(100) 0(0) 26(96)  
Secondary clarifier  
(n=0) 0(0) 0(0) 0(0) 0(0)  
Effluent (n=0) 0(0) 0(0) 0(0) 0(0)  
Total (n=47) 0(0) 47(100) 0(0) 35(75)  
Midwest 1 (n=69)          
Influent (n=22) 0(0) 19(86) 3(14) 9(47)  
Post aeration (n=21) 0(0) 21(100) 0(0) 20(95)  
Secondary clarifier 
(n=13) 0(0) 13(100) 0(0) 13(100)  
Effluent (n=13) 0(0) 13(100) 0(0) 13(100)  
Total (n=69) 0(0) 66(96) 3(4) 55(83)  
Midwest 2 (n=24)          
Influent (n=24 ) 24(100) 0(0) 0(0) 0(0)  
Cell B  (n=0) 0(0) 0(0) 0(0) 0(0)  
Effluent  (n=0) 0(0) 0(0) 0(0) 0(0)  
Total (n=24) 24(100) 0(0) 0(0) 0(0)  
a
SCCmec types I, III, V, and VI were not identified in any sample.   
b







Figure 1 (Reproduced with permission from Environmental Health Perspectives): 
Schematic of wastewater treatment processes at four wastewater treatment plants in 
the Mid-Atlantic and Midwest regions of the United States. Sampling locations are 
indicated with numbers.  Numbers correspond to the following sampling locations: 
Mid-Atlantic WWTP1 and Mid-Atlantic WWTP2: 1=Influent, 2=Activated sludge 
reactor, 3=Post aeration, 4=Effluent; Midwest WWTP1: 1=Influent, 2=Post aeration, 







Figure 2: Resistance to antimicrobial agents detected among MRSA isolates at (a) Mid-Atlantic WWTP1, (b) Mid-Atlantic WWTP2, 





Figure 3: Resistance to antimicrobial agents detected among MSSA isolates at (a) Mid-Atlantic WWTP1, (b) Mid-Atlantic WWTP2, 





Figure 4: Percentage of multidrug-resistant (resistant to two or more classes of 







Figure 5: Pulsed field gel electrophoresis (PFGE)-based dendrogram, antimicrobial resistance profile, SCCmec type, PVL status, and 
source of a representative subset of MRSA isolates recovered from wastewater.  The dendrogram is based on PFGE analysis from 
BioNumerics software.  Clusters were based on ≥88% similarity and are outlined with boxes.  For antimicrobial resistance 
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Vancomycin-resistant enterococci (VRE) are a leading cause of hospital-
acquired infections and are associated with increased mortality rates.  VRE has been 
detected in wastewater throughout the treatment process, but to our knowledge no 
previous studies have analyzed the presence of VRE at wastewater treatment plants 
(WWTPs) that send their treated effluent to reuse sites.  As wastewater reuse becomes 
more common in the U.S. it becomes even more important to determine whether VRE 
and other important human pathogens could survive wastewater treatment and be 
distributed in reclaimed water.  In this study we evaluated the presence, 
concentration, and antimicrobial resistance patterns of VRE at four U.S. municipal 
WWTPs. 
Methods 
We collected 44 wastewater samples from four WWTPs – two in the Mid-
Atlantic and two in the Midwest region of the U.S.  Samples were analyzed for total 
enterococci and VRE using standard membrane filtration.  Isolates were confirmed 
using biochemical tests and polymerase chain reaction.  Antimicrobial susceptibility 
testing was performed by Sensititre® microbroth dilution.  Data were analyzed by 
two-sample proportion tests and analysis of variance. 
Results 
Twenty-seven percent of all wastewater samples collected were positive for 





samples were VRE-positive from the Mid-Atlantic compared to the Midwest WWTPs 
(p = 0.008).  In general, the concentration of VRE decreased as treatment progressed 
at all WWTPs, except at Mid-Atlantic WWTP1 where there was an increase in VRE 
concentrations in samples from the activated sludge reactor.  VRE was not detected in 
disinfected effluent, but was detected in one un-chlorinated effluent sample.  All 
phenotypically unique VRE isolates from all WWTPs were multidrug resistant.  
Fifty-five percent (12/22) of the isolates displayed high-level aminoglycoside 
resistance. 
Conclusions 
Chlorination seems to effectively reduce the occurrence of VRE in 
wastewater. However, WWTP workers could be exposed to VRE during the 
treatment process.  Our data also show that individuals who come into contact with 






Background   
The number of hospitalizations associated with antibiotic-resistant infections 
in the United States nearly quadrupled between 1997 and 2006 (Mainous et al. 2011).  
One antibiotic-resistant pathogen of particular concern is vancomycin-resistant 
enterococci (VRE), an opportunistic gram-positive bacterium resistant to vancomycin 
– “a last resort drug” – that can cause urinary tract infections, as well as wound 
infections, septicemia, meningitis, and endocarditis (CDC 2008; Wegener et al. 
1999).  The first cases of enterococci with high levels of resistance to vancomycin 
were reported in the United Kingdom in the 1980s, and as of 2008 VRE was the third 
leading cause of hospital acquired infections in the U.S. (Hidron et al. 2008; Uttley et 
al. 1988). 
 
In addition to the ability of VRE to cause multiple types of severe infections, 
this bacterium is a major public health concern because of its propensity to acquire 
and transfer mobile resistance genes (Hayakawa et al. 2012).  Acquisition of 
vancomycin resistance genes can take place between strains of enterococci, but 
vancomycin resistance genes can also be transferred from enterococci to other types 
of bacteria, including Staphylococcus aureus (NIAID 2009; Sievert et al. 2008).  The 
Michigan Department of Community Health reported the first clinical isolate of 
vancomycin-resistant S. aureus (VRSA) in 2002 (Sievert et al. 2008).  VRSA is cause 
for concern because of the limited treatment options for this type of infection.  As of 
2012, only 13 clinical cases of VRSA had been confirmed in the United States, but 





genes can also be transferred among isolates originating from different environmental 
and clinical settings, such as from clinical strains released into wastewater to 
community strains contained in the wastewater (Guardabassi and Dalsgaard 2004).  
Because of the ability of enterococci to survive for long periods of time in water (18-
30 days at room temperature), it could be cycled between clinical and environmental 
settings, and cause re-exposure among humans (Lleò et al. 2005; NIAID 2009; Talebi 
et al. 2008).  Previous studies have detected VRE at different stages in the wastewater 
treatment process, including in treated effluent, suggesting that VRE present in 
wastewater effluent could be partially responsible for the dissemination of VRE in 
human communities (Araujo et al. 2010; Caplin et al. 2008; Harwood et al. 2001; 
Kotzamanidis et al. 2009; Luczkiewicz et al. 2010; Morris et al. 2012; Nagulapally et 
al. 2009; Poole et al. 2005; Shannon et al. 2007; Talebi et al. 2008).  In light of the 
growing number of antibiotic-resistant infections and the increase in reclaimed water 
usage in the U.S. (Miller 2011), it is important to assess whether VRE are able to 
survive treatment at wastewater treatment plants (WWTPs) that supply effluent for 
reuse applications. 
 
To our knowledge, there are no published studies analyzing municipal 
wastewater intended for reuse for the presence of VRE.  Also, to our knowledge, no 
studies have specifically evaluated wastewater from the U.S. Mid-Atlantic region for 
the presence of VRE.  A study by Nagulapally et al. (2009) is the only study to 
evaluate wastewater for VRE from a WWTP in the U.S. Midwest region.  In the 





located in the Mid-Atlantic and the Midwest regions of the United States from which 
treated wastewater is reused at spray irrigation sites.  We also analyzed the 








Four U.S. WWTPs that distribute treated effluent to reuse sites were included 
in this study: two in the Mid-Atlantic region and two in the Midwest (Rosenberg 
Goldstein et al. 2012).  Sites in the Mid-Atlantic and Midwest were chosen to be able 
to compare WWTPs in two climatically different regions of the United States.  The 
WWTPs were previously described in detail in Rosenberg Goldstein et al. (2012) 
(Rosenberg Goldstein et al. 2012).  Briefly, Mid-Atlantic WWTP1 is a tertiary 
WWTP in an urban area.  Mid-Atlantic WWTP2, is a tertiary WWTP in a suburban 
area.  Tertiary wastewater treatment includes primary treatment (physical removal of 
solids), secondary treatment (biological treatment), and additional treatment that can 
include, but is not limited to, chlorination, ultraviolet (UV) radiation, or filtration.  
The incoming wastewater (influent) at both Mid-Atlantic plants includes domestic 
and hospital wastewater, and effluent (discharge) from both Mid-Atlantic plants is 
piped to landscaping sites for reuse in spray irrigation.  Midwest WWTP1 is a tertiary 
WWTP in a rural area.  The incoming water includes domestic wastewater and 
agriculturally influenced stormwater.  Seasonal chlorination occurs in June, July, and 
August, and chlorinated effluent is piped to a landscaping site for reuse in spray 
irrigation.  Midwest WWTP2, is a secondary WWTP (with no on-site disinfection) in 
a rural area.  Secondary wastewater treatment includes only primary treatment 
(physical removal of solids) and secondary treatment (biological treatment).  The 





production facility, and agriculturally influenced stormwater.  Unchlorinated effluent 
is piped to an agricultural site for crop irrigation. 
 
Sample collection 
Samples were collected throughout the treatment process at all four WWTPs 
to determine whether certain treatment steps cause the concentration of culturable 
VRE to increase or decrease, as previous studies have suggested that the 
concentration of antibiotic-resistant bacteria differs depending on the treatment step 
sampled (Börjesson et al. 2009; Kim and Aga 2007; Nakamura and Shirota 1990).  A 
total of 44 grab samples were collected between October 2009 and October 2010: 
12 samples from Mid-Atlantic WWTP1; 8 samples from Mid-Atlantic WWTP2; 
12 samples from Midwest WWTP1; and 12 samples from Midwest WWTP2 
(Rosenberg Goldstein et al. 2012).  The timing of each sampling event was dependent 
on the availability and schedule of the WWTP operators.  Samples were collected in 
1‑L sterile polyethylene Nalgene® Wide Mouth Environmental Sample Bottles 




Standard membrane filtration was used to recover total enterococci and VRE 
from the water samples (EPA 2002).  Briefly, ten-fold serial dilutions in the range of 





ml for secondary clarifier and cell B samples were prepared using sterilized 
phosphate buffered saline (PBS) and filtered through 0.45 µm, 47 mm mixed 
cellulose ester filters (Millipore, Billerica, MA).  One liter of non-diluted effluent 
samples was also filtered in the same fashion.  Filters were then plated in duplicate on 
membrane-Enterococcus Indoxyl-β-D-Glucoside (mEI) agar (EMD Millipore, 
Billerica, MA) to isolate total enterococci and mEI agar amended with 16 µg/mL of 
vancomycin to isolate VRE.  Plates were incubated at 41°C for 24 hr.  Resulting 
colonies with blue halos were considered presumptive total enterococci and VRE.  
These colonies were purified on Brain Heart Infusion (BHI) agar (Becton, Dickinson 
and Company, Franklin Lakes, NJ) and archived in Brucella broth (Becton, Dickinson 
and Company) with 15% glycerol at -80°C.  Enterococcus faecalis ATCC 29212 was 
used as a positive control and PBS was used as a negative control throughout the 
isolation process for quality control and quality assurance. 
 
Identification 
VRE was confirmed using the Gram stain, the catalase test, and by detection 
of pyrrolidonyl peptidase (pyr) activity (Remel, Lenexa, KS).  For confirmation, a 
multiplex PCR assay developed by Micallef et al. was used (Micallef et al. 2013).  
Genomic DNA from VRE was extracted by heat lysis as described by Micallef et al. 
(Micallef et al. 2013).  Briefly, the PCR reaction targeted the D-alanine:D-alanine 
ligase (ddl) genes of E. faecalis and E. faecium, the vancomycin resistance-encoding 
vanC1 and vanC2/3 genes of E. gallinarum and E. casseliflavus, respectively, and an 





amplification consisted of an initial denaturing step of 95°C for 3 min, followed by 35 
cycles of denaturing at 94°C for 30 s, annealing at 54°C for 30 s, and extension at 
72°C for 30 s, with a final extension at 72°C for 5 min.  Positive controls used for 
PCR amplification were E. faecalis ATCC 51299, E. faecium ATCC 51559, E. 
casseliflavus ATCC 25788, and E. gallinarum ATCC 49573. 
 
Antimicrobial susceptibility testing 
Antimicrobial susceptibility testing was performed using the Sensititre® 
microbroth dilution system in accordance with the manufacturer’s instructions on all 
confirmed VRE (n=34) and vancomycin-intermediate enterococci (VIE) (n=22) 
isolates (Trek Diagnostic Systems Inc., Cleveland, OH).  Overnight cultures were 
transferred to sterile demineralized water (Trek Diagnostic Systems) to achieve a 0.5 
McFarland standard.  Then, 50 µL of each suspension was transferred to sterile 
cation-adjusted Mueller Hinton broth (Trek Diagnostic Systems), and 50 µL of the 
broth solution was then dispensed into GPN3F or custom designed CMV5ACDC 
minimal inhibitory concentration (MIC) plates (Trek Diagnostic Systems) that 
included the following antibiotics (range of concentrations in µg/ml): erythromycin 
(ERY; 0.25-8), quinupristin/dalfopristin (SYN; 0.12-32), vancomycin (VAN; 1-128), 
tetracycline (TET; 2-32), gentamicin (GEN; 2-16, 128-1024), linezolid (LZD; 0.5-8), 
streptomycin (STR; 512-2048), penicillin (PEN; 0.06-16), and ciprofloxacin (CIP; 
0.5-4).  E. faecalis ATCC 29212 and S. aureus ATCC 29213 were used as quality 
control strains.  MICs were recorded as the lowest concentration of an antimicrobial 





published by the Clinical and Laboratory Standards Institute were used (CLSI 2013).  
Multidrug resistance (MDR) was defined as resistance to two or more classes of 
antibiotics. 
 
Statistical analyses  
Descriptive statistics included the percentage of wastewater samples that were 
positive for VRE and the percentage of VRE species by WWTP.  A two-sample test 
of binomial proportions was used to compare the percentage of positive VRE samples 
between the Mid-Atlantic and the Midwest WWTPs.  To describe total enterococci 
and VRE concentrations, both CFU/100 ml and log CFU/100 ml were calculated.  
One-way analysis of variance (ANOVA) was then used to compare the average log 
concentration of presumptive VRE by sampling location for each WWTP.  In all 
cases, p-values of ≤ 0.05 were defined as statistically significant.  All statistical 







Presence and concentration of VRE 
VRE were detected at all WWTPs in this study and made up 3% of the total 
enterococci (Table 1).  Total enterococci were detected at all WWTPs in all treatment 
steps, including chlorinated effluent.  Across all treatment plants sampled, 27% 
(12/44) of the wastewater samples were positive for VRE:  45% (9/20) of samples 
from the Mid-Atlantic WWTPs; and 13% (3/24) of samples from the Midwest 
WWTPs (p = 0.008).  Thirty-three percent (4/12) of influent samples from all of the 
WWTPs were VRE-positive; 60% (3/5) from the Mid-Atlantic WWTPs and 14% 
(1/7) from the Midwest WWTPs.  The percentage of VRE increased in the activated 
sludge reactor step at both Mid-Atlantic WWTP1 and Mid-Atlantic WWTP2 but 
decreased to undetectable levels in the effluent.  At Midwest WWP1 the percentage 
of VRE increased as treatment progressed, with the highest percentage of VRE 
present in the effluent (Table1).  No confirmed VRE were detected in any tertiary-
treated (chlorinated) effluent samples.  However, VRE was detected in one effluent 
sample from Midwest WWTP1 in October 2010 when chlorination was not being 
used. 
   
 In general, the average concentration of presumptive VRE at each WWTP 
decreased as treatment progressed (Figure 1).  Looking at all sampling dates 
combined, there were significant differences in the VRE concentrations between 
treatment steps at all WWTPs, except at Midwest WWTP 2 where VRE was only 





WWTP2 p = 0.001; Midwest WWTP1 p ≤ 0.001).  At Mid-Atlantic WWTP1, 
assessing all sampling dates, there was a slight increase in presumptive VRE 
concentrations in the activated sludge reactor from 1.9 x 10
4 
CFU/100 mls in influent 
to 1.9 x 10
5 
CFU/100 mls in the activated sludge reactor.  At all WWTPs, the lowest 
concentration of VRE was detected in the effluent samples, with no VRE identified in 
the effluent at Mid-Atlantic WWTP1, Mid-Atlantic WWTP 2, or Midwest WWTP2. 
 
The majority of VRE isolates from all WWTPs were identified as E. faecium 
(78.26%), followed by E. faecalis (17.39%), and E. gallinarium (4.35%) (Table 2). 
 
Presence of VIE 
VIE were detected at all WWTPs in this study except for Mid-Atlantic 
WWTP1.  No VIE were detected in any of the tertiary-treated (chlorinated) effluent 
samples.  However, similar to VRE, VIE was detected in one effluent sample from 
Midwest WWTP1 in October 2010 when chlorination was not taking place.  VIE 
isolates from all of the WWTPs were identified as E. gallinarium (78.95%) and E. 
casseliflavus (21.05%) (Table 3). 
 
Antibiotic resistance patterns 
In total, 34 VRE isolates were isolated from the four WWTPs.  However, only 
22 isolates that could be identified as unique using phenotypic analyses were included 
in the analysis of antibiotic resistance patterns in order to eliminate bias that would 





species, from all WWTPs were MDR.  The resistance patterns among unique isolates 
varied by WWTP. 
 
The VR E. faecium isolates (n=13) from Mid-Atlantic WWTP1 were resistant 
to multiple antibiotics used to treated enterococci infections including penicillin, 
ciprofloxacin, and streptomycin (Figure 2a).  The percentage of resistant VR E. 
faecium isolates were mostly constant throughout the treatment process at this 
particular WWTP, except for an increasing percentage of isolates displaying 
resistance to streptomycin progressing through the treatment process and a spike in 
the percentage of isolates resistant to tetracycline in the activated sludge reactor 
(Figure 2a).  Four VR E. faecalis isolates were detected at Mid-Atlantic WWTP1 
(one from influent, one from the activated sludge reactor, and two from the secondary 
clarifier) (Figure 2b).  All of the VR E. faecalis isolates were also resistant to 
erythromycin, quinupristin/dalfopristin, tetracycline, vancomycin, and ciprofloxacin.  
Three out of four VR E. faecalis isolates from Mid-Atlantic WWTP1 were resistant to 
gentamicin (one from the activated sludge reactor and two from the secondary 
clarifier), two of the four isolates were resistant to streptomycin (both from the 
secondary clarifier), and the one isolate from the influent was resistant to penicillin 
(Figure 2b). 
 
 At Mid-Atlantic WWTP2 the one unique VR E. gallinarum isolate was 
resistant to quinupristin/dalfopristin in addition to vancomycin.  The three unique VR 





from the effluent) were all resistant to erythromycin, penicillin, vancomycin, and 
ciprofloxacin.  From Midwest WWTP2, the one VR E. faecium isolate from the 
influent expressed resistance to erythromycin, penicillin, tetracycline, vancomycin, 
ciprofloxacin, and streptomycin. 
 
In total, 22 VIE isolates were isolated from Mid-Atlantic WWTP2, Midwest 
WWTP1, and Midwest WWTP2, however only 19 isolates that could be identified as 
phenotypically unique were included in the analysis of antibiotic resistance patterns.  
The isolates were resistant or intermediately resistant to a number of clinically 
relevant antibiotics including erythromycin, tetracycline, and ciprofloxacin, although 
patterns differed by treatment plant (Figure 3).  At Mid-Atlantic WWTP2 and 
Midwest WWTP1 the percentage of resistant or intermediately resistant isolates 
generally remained the same or increased as treatment progressed (Figure 3).  At 







Occurrence of VRE 
Previous studies have detected VRE in all wastewater treatment steps, 
including effluent samples, however to our knowledge this is the first study to 
evaluate the occurrence of VRE at a WWTP in the Mid-Atlantic region of the U.S. 
and to evaluate wastewater intended for reuse (Araujo et al. 2010; Caplin et al. 2008; 
Kotzamanidis et al. 2009; Morris et al. 2012).  We identified VRE in 27% of all 
samples from all WWTPs, including an un-chlorinated effluent sample from Midwest 
WWTP1 (a WWTP that chlorinates only in summer).  The majority of studies 
assessing the presence of VRE in wastewater have been conducted in Europe and 
found VRE prevalence ranging from 2-52% (Kotzamanidis et al. 2009; Luczkiewicz 
et al. 2010; Morris et al. 2012).  Interestingly, VRE was isolated in 2-3% of samples 
from European secondary WWTPs (Luczkiewicz et al. 2010; Morris et al. 2012), and 
in 52% of wastewater samples from a tertiary WWTP using chlorination 
(Kotzamanidis et al. 2009).  To our knowledge, Nagulapally et al. (2009) is the only 
published study to have detected VRE at a U.S. municipal WWTP (Nagulapally et al. 
2009).  Similar to our findings of VRE in influent and biologically treated samples 
(from the activated sludge reactors, post aeration, and secondary clarifiers) but not in 
tertiary-treated effluent, Nagulapally et al. (2009) isolated VRE from influent and 
secondary clarifier samples, but not from UV-disinfected effluent samples 






Many prior studies have also concluded that VRE concentrations decreased as 
wastewater treatment progressed; however VRE has been detected in effluent 
including disinfected effluent (Kotzamanidis et al. 2009; Morris et al. 2012; 
Nagulapally et al. 2009).  In the current study we found that the concentration of VRE 
significantly decreased as treatment progressed at most WWTPs where samples were 
collected (Figure 1).  At Mid-Atlantic WWTP1, there was a slight increase in the 
concentration of VRE in the activated sludge reactor step.  Also at Mid-Atlantic 
WWTP1 and Mid-Atlantic WWTP2 the proportion of VRE out of total enterococci 
was highest in the activated sludge reactor step (Table 1).  Previous studies have also 
found an increase in the concentration or percentage of antibiotic-resistant bacteria in 
the secondary treatment step, and specifically activated sludge reactors, which 
decreased with tertiary treatments (Börjesson et al. 2009; Luczkiewicz et al. 2010; 
Nakamura and Shirota 1990). 
 
 The un-chlorinated effluent sample from Midwest WWTP1 that contained a 
confirmed VRE isolate is from the same WWTP and sampling date (October 2010) 
where MRSA was detected in a previous study by our group (Rosenberg Goldstein et 
al. 2012), suggesting that chlorination is important for reducing the presence of 
multiple types of antibiotic-resistant bacteria in wastewater. 
 
Regional differences 
 The different VRE prevalence rates between WWTPs in the Mid-Atlantic 





geographic differences in human VRE infection rates (Bouchillon et al. 2005; 
CDDEP 2013).  Since 2004, more VRE has been isolated in the Mid-Atlantic region 
of the U.S. compared to the Midwest region (Bouchillon et al. 2005; CDDEP 2013).  
Assessing VR E. faecalis and VR E. faecium individually, regional differences are 
still apparent although less pronounced for VR E. faecalis (CDDEP 2013).  The 
regional differences in clinically confirmed VRE in the U.S. could be due, in part, to 
aggressive intervention and control efforts undertaken in the late 1990s at acute and 
long-term care facilities in Iowa, Nebraska, and South Dakota, including isolation of 
patients colonized with VRE and greater emphasis on handwashing and cleaning 
(Low et al. 2001; Ostrowsky et al. 2001).  The prevalence of VRE in facilities that 
participated in the intervention program in this region decreased from 2.2% to 0.5% 
between 1997 and 1999 (Ostrowsky et al. 2001).  In addition to differences in human 
VRE infection rates between the Midwest and Mid-Atlantic regions, the WWTPs 
sampled from these regions differed by surrounding land uses and types of influent 
received.   The Mid-Atlantic WWTPs are located in urban and suburban settings and 
receive domestic and hospital influent, whereas both Midwest WWTPs are located in 
rural areas and receive agriculturally influenced stormwater in addition to domestic 
wastewater (Rosenberg Goldstein et al. 2012).   
 
Species diversity 
E. faecium was the dominant species of VRE identified in wastewater samples 
in this study (78.26%).  Because wastewater contains human excreta, and E. faecium 





infections, our findings on species diversity verified our expectations (Table 1) 
(Hayakawa et al. 2012).  Several previous studies in Europe and Iran that have 
analyzed species diversity among VRE isolated from wastewater also found a greater 
percentage of VRE faecium than VRE faecalis in this type of water (Araujo et al. 
2010; Kotzamanidis et al. 2009; Luczkiewicz et al. 2010; Morris et al. 2012; Talebi et 
al. 2008).  In addition, acquired antibiotic resistance is generally more common 
among E. faecium than E. faecalis because of its greater ability to acquire resistance 
genes (Araujo et al. 2010; Fisher and Phillips 2009; Giraffa 2002).  In a study of 
clinical VRE species diversity, Deshpande et al. (2007) found that 92.8% of VRE 
isolates from 26 U.S. sites were E. faecium (Deshpande et al. 2007).  However, the 
study by Nagulapally et al. (2009) that detected VRE at one U.S. municipal WWTP 
in the Midwest region found a greater percentage of E. faecalis among VRE isolates 
than any other species (Nagulapally et al. 2009). 
 
Antibiotic resistance patterns 
The presence of high-level aminoglycoside resistance (HLAR) in more than 
half (54.5%) of the enterococci isolated in this study is cause for concern given that 
the current international guidelines for treatment of Enterococcus infections 
recommend a combination of ampicillin or penicillin and an aminoglycoside 
antibiotic (including gentamicin, streptomycin and kanamycin) (Fernández-Hidalgo et 
al. 2013).  Fifty percent (9/18) of VR E. faecium isolates from all of the WWTPs 
sampled in this study were resistant to streptomycin, and none were resistant to 





WWTP1, 25% (1/4) were streptomycin-resistant and 75% (3/4) were gentamicin-
resistant.  Gentamicin-resistance has previously been found to be more prevalent 
among clinical VRE faecalis isolates compared to VRE faecium (Deshpande et al. 
2007).  Previous studies have also isolated HLAR enterococci and VRE from 
wastewater samples and found a wide range of the prevalence of VRE displaying 
HLAR (Kotzamanidis et al. 2009; Luczkiewicz et al. 2010; Rice et al. 1995; Talebi et 
al. 2008; Tejedor Junco et al. 2001).  Rice et al. (1995) detected enterococci resistant 
to both gentamicin and streptomycin at U.S. secondary WWTPs, although 
gentamicin-resistant Enterococcus spp. were only isolated from a treatment plant 
receiving both hospital and domestic sewage, as opposed to only domestic waste 
(Rice et al. 1995).  One E. faecalis isolate resistant to gentamicin, streptomycin, and 
kanamycin was identified in secondary-treated wastewater effluent in a study by 
Tejedor Junco et al. (2001) in Spain (Tejedor Junco et al. 2001).  Luczkiewicz et al. 
(2010) found high-level resistance to gentamicin and streptomycin among 4.5% and 
6.3% of E. faecium and 2.3% and 6.8% of E. faecalis isolates, respectively, from 
wastewater samples (Luczkiewicz et al. 2010).  Among VR E. faecalis isolates 
collected from municipal wastewater, Kotzamanidis et al. (2009) reported that 5% 
had high-level gentamicin resistance and 95% had high-level streptomycin-resistance 
(Kotzamanidis et al. 2009).  Twenty-five percent and 75% of VR E. faecium isolates, 
respectively from wastewater and sludge from Portuguese WWTPs were resistant to 
gentamicin and streptomycin (Araujo et al. 2010).  Talebi et al. (2008) found that 
95% of VRE isolates from a WWTP in Tehran were gentamicin-resistant (Talebi et 







Our finding that 100% of the VRE isolates detected in this study were MDR is 
consistent with findings from previous studies analyzing VRE from wastewater.  
Talebi et al. (2008), Kotzamanidis et al. (2009), and Araújo et al. (2010) found that 
100% of VRE faecium isolates detected in samples collected from municipal WWTPs 
were MDR (Araujo et al. 2010; Kotzamanidis et al. 2009; Talebi et al. 2008).  
Because multidrug resistance further limits treatment options for infections, this 
finding is concerning considering occupational exposure to wastewater among 
WWTP workers.   
 
Public health implications 
Our study raises possible public health concerns for WWTP workers exposed 
to wastewater and for individuals exposed to treated wastewater when it is reused.  
Based on data from numerous studies, WWTP workers tend to report higher levels of 
gastrointestinal (GI) and respiratory disease symptoms compared to the general 
population, although there is conflicting evidence about increased risks of infection 
due to specific pathogens identified in wastewater (Glas et al. 2001; Khuder et al. 
1998; Seuri et al. 2005; Thorn and Kerekes 2001).  A review of the literature through 
2001 by Thorn and Kerekes (2001) found that several studies identified WWTP 
workers as more likely to report GI and respiratory symptoms and more likely to have 
antibodies against hepatitis A (Thorn and Kerekes 2001).  Few of the studies analyzed 





infections among WWTP workers (Thorn and Kerekes 2001).  Khuder et al. (1998) 
found that a greater proportion of WWTP workers reported gastroenteritis than 
controls, but again no specific microbial agents were identified as causing these 
symptoms (Khuder et al. 1998).  A Finnish study interested in determining whether 
the increased risk of diarrheal disease among wastewater treatment plant workers was 
attributable to Salmonella found that although more GI symptoms were reported by 
WWTP workers than controls, there was no significant difference in Salmonella 
antibody levels between the two groups (Seuri et al. 2005).  Because VRE was 
identified at all WWTPs included in the current study, enterococci, and VRE in 
particular, could potentially cause infections among WWTP workers.  Also, because 
VRE was identified in the final effluent at Midwest WWTP1, and the effluent from 
this WWTP is sent to a reuse site for irrigation, individuals exposed to reclaimed 
water could also be at risk for exposure to VRE.  Interventions aimed at reducing 
VRE exposures and infections in clinical facilities including education and increased 
handwashing have been found to be effective (Low et al. 2001; Ostrowsky et al. 
2001).  Improving awareness about VRE, and other human pathogens, at WWTPs 
and encouraging handwashing could be important interventions to explore to reduce 
potential exposure among WWTP workers. 
 
Limitations 
As with all field studies, there are limitations to this study.  If VRE were 
injured or otherwise present in a viable but nonculturable state, they would not have 





possibly resulting in underestimations of VRE occurrence and concentrations (Lleò et 
al. 2005; Lleò et al. 2001).  The concentrations of VRE could also have been 
underestimated because of the use of grab samples in this study.  Also, the 
generalizability of our results is limited because we sampled only four WWTPs in 







VRE was detected for the first time in wastewater at four U.S. WWTPs whose 
effluent is intended for reuse and at Mid-Atlantic WWTPs.  The concentration of 
VRE decreased as treatment progressed, although at both Mid-Atlantic WWTPs the 
proportion of VRE out of total enterococci increased in the activated sludge step.  
VRE was only isolated in one effluent sample at a treatment plant during a month 
when chlorination was not taking place.  Because the WWTP where VRE was found 
in effluent sends its treated wastewater to a reuse site, individuals exposed to 
reclaimed water at that site could be potentially exposed to VRE.  All phenotypically 
unique VRE isolates from all WWTPs sampled in this study were MDR, and 
specifically resistant to a number of antibiotics used to treat VRE infections, 
including the aminoglycosides gentamicin and streptomycin.  WWTP workers and 
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Table 1. Average concentration of total enterococci and vancomycin-resistant 







(CFU/100 mls) Percentage of VRE 
Mid-Atlantic WWTP1 
   Influent 7.17E+06 1.93E+04 0.3 
Activated Sludge Reactor 4.64E+05 1.89E+05 40.7 
Secondary Clarifier 1.49E+03 9.60E+01 6.5 
Effluent 1.04E+00 0.00E+00 0.0 
Mid-Atlantic WWTP2 
   Influent 1.73E+06 8.56E+04 4.9 
Activated Sludge Reactor 2.19E+05 1.32E+04 6.0 
Secondary Clarifier 1.86E+04 8.46E+02 4.6 
Effluent 5.00E-02 0.00E+00 0.0 
Midwest WWTP1 
   Influent 1.21E+06 4.03E+04 3.3 
Post Aeration 6.34E+04 8.55E+02 1.3 





   Influent 5.30E+05 2.52E+03 0.5 
Cell B 5.08E+02 0.00E+00 0.0 
Effluent 6.05E+01 0.00E+00 0.0 
Total 1.14E+07 3.52E+05 3.1 
 
a 






Table 2. Number and percentage of vancomycin-resistant enterococci (VRE) isolates 
by species and wastewater treatment plant 
 
 











E. faecium 14 (77.78) 0 (0) 3 (100) 1 (100) 18 (78.26) 
E. faecalis 4 (22.22) 0 (0) 0 (0) 0 (0) 4 (17.39) 







Table 3. Number and percentage of vancomycin-intermediate enterococci (VIE) 
isolates by species and wastewater treatment plant 
 
 











E. gallinarum 0 (0) 5 (83.33) 6 (75) 4 (80) 15 (78.95) 









Figure 1: Concentration of presumptive vancomycin-resistant enterococci (VRE) by 
wastewater treatment plant and sampling location.    
 
A. Mid-Atlantic WWTP1        
 
 




















Figure 2: Resistance to antimicrobial agents detected at Mid-Atlantic WWTP1 
among (a) vancomycin-resistant Enterococcus (VRE) faecium and (b) VR E. faecalis 
isolates. 
 
A. VR E. faecium 
 






Figure 3: Resistance and intermediate resistance to antimicrobial agents detected 
among vancomycin-intermediate enterococci (VIE) isolates at (a) Mid-Atlantic 
WWTP2, (b) Midwest WWTP1, and (c) Midwest WWTP2. 
 
A. Mid-Atlantic WWTP2       
  
 
B. Midwest WWTP1 
 








Chapter 5: Occupational exposure to Staphylococcus aureus and 
Enterococcus spp. among spray irrigation workers using 
reclaimed water 
 
(Rosenberg Goldstein RE, Micallef SA, Gibbs SG, He X, George A, Sapkota A, 
Joseph SW, and Sapkota AR. Occupational exposure to Staphylococcus aureus and 
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As reclaimed water use expands, it is important to evaluate potential health 
risks from exposure to this water source. We compared odds of colonization with 
methicillin-resistant Staphylococcus aureus (MRSA), methicillin-susceptible S. 
aureus (MSSA), vancomycin-resistant enterococci (VRE), and vancomycin-




Nasal and dermal swabs from 19 spray irrigation workers and 24 controls 
were collected and analyzed for MRSA, MSSA, VRE, and VSE. Isolates were 
confirmed and antimicrobial susceptibility testing was performed by microbroth 
dilution.  Data were analyzed by two-sample proportion, chi-square, and Fisher’s 
exact tests, and logistic regression. 
 
Results 
No MRSA or VRE were detected in any samples. MSSA was detected in 26% 
and 29% of spray irrigation workers and controls. VSE was detected in 11% and 0% 
of spray irrigation workers and controls. The odds of MSSA, multidrug-resistant 
MSSA, and either MSSA or VSE colonization were not significantly different 







Reclaimed water spray irrigation workers may be occupationally exposed to 
human pathogens based on the detection of pathogens in wastewater intended for 
reuse in previous studies. Future studies with larger sample sizes are needed to further 







Between 5-6% of municipal wastewater effluent, approximately 2.22 billion 
gallons per day, is reclaimed and reused in the United States (Miller 2011).  
Landscape irrigation is one of the most common uses of reclaimed water in the U.S., 
making up 18% of all water reused across the country (EPA 2012; NRC 2012).  
Although irrigation with reclaimed water is growing, limited data exists on pathogens 
present in reclaimed water, as well as health risks from exposure to this water source 
(Blumenthal et al. 2001; Devaux et al. 2001; Durand and Schwebach 1989; Harwood 
et al. 2005; Jjemba et al. 2010).  Some studies have identified several bacterial and 
parasitic species in wastewater intended for reuse (Blumenthal et al. 2001; Harwood 
et al. 2005; Jjemba et al. 2010; Rosenberg Goldstein et al. 2012).  Methicillin-
resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci 
(VRE) have both been identified in wastewater throughout the treatment process, 
including final effluent in the U.S. and Europe (Araujo et al. 2010; Börjesson et al. 
2009; Börjesson et al. 2010; Kotzamanidis et al. 2009; Nagulapally et al. 2009; 
Rosenberg Goldstein et al. 2012).  Several studies have suggested that wastewater, 
and the reuse of wastewater, could be a source of exposure to these resistant bacteria, 
as well as other human pathogens, in the community (Börjesson et al. 2009; Plano et 
al. 2011; Rosenberg Goldstein et al. 2012).  As rates of antibiotic-resistant bacterial 
infections in hospitals and the community continue to rise (Mainous et al. 2011), 
including infections with MRSA and VRE, it is important to evaluate whether 
reclaimed water could serve as a potential source of exposure to these particular 






Staphylococcus aureus is a bacterial pathogen that colonizes multiple body 
sites, most commonly the nostrils, and causes a number of infections, including 
dermal and soft tissue infections, pneumonia, and septicemia (Bassetti et al. 2009).  
MRSA and methicillin-susceptible S. aureus (MSSA) have been detected in air 
samples from a number of environments, including wastewater treatment plants 
(Fracchia et al. 2006; Gandara et al. 2006; Gibbs et al. 2006; Schulz et al. 2012).  
Since these bacteria can be aerosolized from water and are capable of colonizing skin 
and soft tissues, exposure through inhalation is of concern, particularly among 
workers at wastewater treatment plants and spray irrigation sites using the reclaimed 
water. 
 
Enterococci are opportunistic pathogens that can cause urinary tract 
infections, bacteremia, and endocarditis (CDC 2008; P Murray et al. 2002; Spacek 
and Vinetz 2009).  Between 2006 and 2007, 13% of hospital infections were caused 
by enterococci, and approximately 30% of these infections were VRE (Hidron et al. 
2008).  VRE and vancomycin-susceptible enterococci (VSE) have been detected in 
wastewater in both raw influent and treated effluent, as well as wastewater 
bioaerosols (Araujo et al. 2010; Caplin et al. 2008; Fracchia et al. 2006; 
Korzeniewska et al. 2009; Kotzamanidis et al. 2009; Luczkiewicz et al. 2010; Morris 
et al. 2012; Nagulapally et al. 2009; Talebi et al. 2008).  Although the exact sources 





wastewater have been suggested as important environmental reservoirs (McDonald 
1997; Poole et al. 2005). 
   
If S. aureus or enterococci survive wastewater treatment and distribution to 
reuse sites, spray irrigation workers could be exposed to these organisms through 
dermal contact or inhalation (Bassetti et al. 2005).  To our knowledge, no previous 
studies have evaluated the risk for occupational exposure to antibiotic-resistant 
bacteria from reclaimed water (Devaux et al. 2001; NRC 2012).  In the present study 
we compared MRSA, MSSA, VRE, and VSE colonization among reclaimed water 









The spray irrigation reuse site described in this study is located in the Mid-
Atlantic region of the U.S.  The site was chosen based on the willingness of the site 
operator to participate in the study.  This site receives treated wastewater from a 
tertiary wastewater treatment plant in the Mid-Atlantic region (Mid-Atlantic 
WWTP1) (Rosenberg Goldstein et al. 2012).  Once the treated wastewater reaches the 
reuse site, it passes through an aluminum screen and is then treated with ultraviolet 
(UV) radiation.  After UV treatment, the water is pumped into an open-air storage 
pond at a rate of 230,000 gallons per day with a peak capacity of 4 million gallons.  
Based on turf irrigation needs, water is then pumped from the storage pond to a pump 
that distributes the water to spray heads.  Spray irrigation workers also carry 
backpack spray systems to irrigate additional areas.  The reuse site employs eight full-
time employees and approximately 22 seasonal employees each year. 
 
Subject Selection 
A total of 43 subjects were enrolled in the study; 19 spray irrigation workers 
from the spray irrigation site who were occupationally exposed to reclaimed water, 
and 24 office workers controls from an academic work setting who were not exposed 
to reclaimed water or healthcare settings on the job.  Study subjects were selected 
through a convenience sample based on employment status.  Office worker controls 





recruited into the study in person and over email.  Individuals were excluded from 
participation if they reported a nosebleed three days prior to sample collection to 
avoid dislodging blood clots. 
 
Survey 
Participants were asked to complete a short survey containing questions 
related to sociodemographics, as well as questions related to risk factors associated 
with MRSA colonization and previous MRSA diagnosis.  The survey also asked 
participants about previous work in healthcare facilities and household members who 
work in healthcare facilities, because S. aureus nasal colonization rates among 
healthcare workers is greater than the 20-30% colonization rate found in the general 
population (FDA 2009; Gorwitz et al. 2008; P Murray et al. 2002).  The survey was 
filled out by participants on site at each sampling event.  
 
Sample Collection 
A total of 94 nasal and 94 dermal swab samples were collected between 
August 2009 and February 2011.  All participants were sampled multiple times when 
possible.   Nasal swabs were collected using, Liquid Stuart Medium Transport swabs 
(Copan, Italy).  The swab was inserted approximately 1.25 cm into the participant’s 
right nostril and gently rotated five times on the inside wall of the nostril (Bassetti et 
al. 2005; Ochei and Kolhatkar 2000; Vegunta et al. 2009).  Dermal swabs were also 
collected using the same type of swabs.  An approximately five-by-five cm area of 





times (Kullander et al. 2009).  All samples were transported to the laboratory at 4°C 
and processed within 24 hr.   
 
Isolation 
All media was obtained from Becton, Dickinson and Company (Franklin 
Lakes, NJ).  Nasal and dermal swabs were streaked onto Baird Parker agar for 
isolation of total S. aureus and Enterococcosel agar for isolation of total Enterococcus 
spp.  Baird Parker agar plates were incubated at 37°C for 24 hr, while Enterococcosel 
agar plates were incubated at 41°C for 24 hr.  Resulting black colonies with halos on 
Baird Parker, and colonies with a black precipitate on Enterococcosel agar were 
considered presumptive S. aureus and enterococci, respectively.  These colonies were 
purified on Brain Heart Infusion agar and archived in Brucella broth with 15% 
glycerol at -80°C.  S. aureus ATCC 43300 and Enterococcus faecalis ATCC 29212 
were used as positive controls and phosphate buffered saline was used as a negative 
control throughout the isolation process. 
 
Confirmation 
S. aureus were identified using the Gram stain, the coagulase test (Becton, 
Dickinson and Company), and the catalase test.  For confirmation of S. aureus and 
MRSA differentiation, the S. aureus-specific nuc gene, the MRSA-specific mecA 
gene, and a 16S rDNA internal control were PCR amplified in a multiplex reaction as 
described previously (Brakstad et al. 1992; Edwards et al. 1989; Fang and Hedin 





performed using the MoBio UltraClean® Microbial DNA Isolation Kit (Mo Bio 
Laboratories, Carlsbad, CA) per the manufacturer’s recommendations.  Briefly, PCR 
amplification consisted of an initial denaturing step of 95°C for 3 min, followed by 34 
cycles of denaturing at 94°C for 30 s, annealing at 55°C for 30 s, and extension at 
72°C for 30 s, with a final extension at 72°C for 5 min.  S. aureus ATCC 43300 was 
used as a positive control for PCR amplification of nuc and mecA genes. 
 
Enterococci were presumptively identified using the Gram stain, the catalase 
test, and by detection of pyrrolidonyl peptidase (pyr) activity (Remel, Lenexa, KS).  
Confirmation was accomplished using a modified multiplex PCR assay previously 
described by Micallef et al. (2013).  Genomic DNA from enterococci was extracted 
by heat lysis as described previously (Micallef et al. 2013).  Briefly, the PCR reaction 
targeted the ddl genes of Enterococcus faecalis and E. faecium, the vanC1 and 
vanC2/3 genes of E. gallinarum and E. casseliflavus, and a 16S rDNA internal 
control (Micallef et al. 2013).  PCR amplification consisted of an initial denaturing 
step of 95°C for 3 min, followed by 35 cycles of denaturing at 94°C for 30 s, 
annealing at 54°C for 30 s, and extension at 72°C for 30 s, with a final extension at 
72°C for 5 min.  Positive controls used for PCR amplification were E. faecalis ATCC 
51299, E. faecium ATCC 51559, E. casseliflavus ATCC 25788, and E. gallinarum 
ATCC 49573. 
 
Colonization among study participants was defined as MRSA, MSSA, VRE, 






Antimicrobial Susceptibility Testing 
We performed antimicrobial susceptibility testing using the Sensititre® 
microbroth dilution system with GPN3F minimum inhibitory concentration (MIC) 
plates (Trek Diagnostic Systems Inc., Cleveland, OH) in accordance with the 
manufacturer’s instructions on all PCR-confirmed S. aureus (n=97) and Enterococcus 
spp. (n=20) isolates.  Details on specific antibiotics and concentrations tested are 
included in Appendix A.  Enterococcus faecalis ATCC 29212 and S. aureus ATCC 
29213 were used as quality control strains.  MICs were recorded as the lowest 
concentration of an antimicrobial that completely inhibited bacterial growth (CLSI 
2013).  Resistance breakpoints published by the Clinical and Laboratory Standards 
Institute were used (CLSI 2013).  Multidrug resistance (MDR) was defined as 
resistance to two or more classes of antibiotics. 
 
Statistical Analyses  
Descriptive statistics were reported including the percentages of nasal and 
dermal swab samples positive for MSSA and VSE by worker classification.  
Differences in sociodemographic variables between spray irrigation workers and 
controls were compared using the chi-square or Fisher’s exact test.  Two-sample tests 
of binomial proportions were used to compare the percentage of spray irrigation 
workers and office worker controls who were colonized with each of the 
microorganisms of interest.  Statistical analyses of antibiotic resistance data were 





resistance profiles; this allowed us to reduce bias that could be introduced by 
including possible clones.  A two-sample t-test was used to compare the number of 
antibiotics isolates were resistant to.  Logistic regression models were used 1) to 
determine if the odds of ever being colonized with the bacteria of interest were 
different for spray irrigation workers compared to controls, while controlling for other 
factors; and 2) to conduct analyses of spray irrigation worker odds of colonization.  A 
generalized linear mixed effects model (GLMM) was used to evaluate the odds of 
being colonized with S. aureus over time by occupational status.  In all cases, p-
values of ≤ 0.05 were defined as statistically significant.  All statistical analyses were 
performed using Stata/IC 10 (StatCorp LP, College Station, TX) and SAS 9.2 (SAS 







The participation rate for the study was 88% (43/49).  Participants ranged in 
age from 17 to 66 years and both spray irrigation workers and office worker controls 
were composed largely of Caucasian males (Table 1).  The mean age of the spray 
irrigation workers and controls was 34 and 33 years, respectively.  None of the 
participants in either group reported previous diagnoses of MRSA.  Of the 
sociodemographic variables collected from participants, there were a few significant 
differences between spray irrigation workers and controls.  Education levels and 
yearly income differed by exposure group (p <0.001; p=0.011).  Spray irrigation 
workers reported “currently smoking” (p=0.002) and “smoking more than 100 
cigarettes in the past six months” (p <0.001) more than the controls (Table 1).  
Slightly more controls reported either personally having worked in a healthcare 
setting or having a household member who had worked in a healthcare setting, but 
these differences were not statistically significant.   
 
Presence of MRSA and MSSA 
No MRSA was detected in any of the nasal or dermal swabs collected from 
the spray irrigation workers or controls.  MSSA was recovered from 28% (12/43) of 
all study participants.  Twenty-six percent (5/19) of spray irrigation workers had nasal 
swabs that were positive for MSSA during at least one sampling event (Figure 1).  
Among controls, 29% (7/24) were positive for MSSA in nasal swabs during at least 





swab samples, but 8% (2/24) of controls were MSSA-positive based on dermal swab 
samples alone.  The probability of ever having been colonized with MSSA from 
either sample type was not significantly different between spray irrigation workers 
and controls (p = 0.836). 
 
Presence of VRE and VSE 
VRE was not detected in any nasal or dermal swab samples from the spray 
irrigation workers or controls (Figure 1).  A greater proportion of spray irrigation 
workers were colonized with VSE compared to controls, but this was not statistically 
significant (11% vs. 0%; p=0.189). 
 
Presence of either of the target bacteria in swab samples 
 Thirty-three percent (14/43) of all participants were colonized with either 
MSSA or VSE.  A greater proportion of spray irrigation workers compared to 
controls were colonized with at least one of the bacteria of interest, but this was not 
statistically significant (p=0.2969) (Figure 1). 
 
Antibiotic resistance patterns 
In total, 97 MSSA isolates were recovered from nasal and dermal swabs: 57 
isolates from spray irrigation workers, and 40 from controls.  However, statistical 
analyses concerning antibiotic resistance patterns among these isolates were limited 





spray irrigation workers; 17 from controls).  Isolates were resistant to a variety of the 
18 antibiotics tested.  A greater percentage of spray irrigation workers compared to 
controls were colonized with MDR MSSA (11% vs. 8.3%) (p=0.4029) (Figure 1) and 
a greater percentage of MSSA isolates from spray irrigation worker swabs were 
resistant to erythromycin (p=0.1260) and linezolid (p=0.1313) (Figure 2).  A greater 
percentage of MSSA isolates from office worker control swabs compared to spray 
irrigation worker swabs were resistant to tetracycline (p=0.1699) and ampicillin 
(p=0.2458) (Figure 2).  MSSA isolates from spray irrigation workers’ nasal swabs 
were resistant to an average of 1.6 antibiotics compared to 1.47 antibiotics among 
control nasal swab MSSA isolates (p=0.3702).   
 
In total, 20 VSE isolates were isolated from two spray irrigation worker nasal 
swabs.  Of the three isolates that were phenotypically unique, all three were resistant 
to rifampicin and all three were either resistant or intermediately resistant to 
quinupristin/dalfopristin. 
 
Impact of occupational exposure on colonization 
Our univariate logistic regression models indicated that the odds of being 
colonized with MSSA, MDR MSSA, or either MSSA or VSE did not differ 
significantly between the spray irrigation workers occupationally exposed to 
reclaimed water and our control group of office workers (Table 2).  Our adjusted, 
multivariate logistic regression model also indicated that the odds of being colonized 





between the spray irrigation workers and controls (Table 2).  Specifically, the odds of 
being colonized with MDR MSSA or either MSSA or VSE were greater among the 
spray irrigation workers compared to the controls in both the unadjusted and adjusted 
models, however, the differences were not statistically significant (Table 2).  In the 
adjusted model, the odds of being colonized with MSSA were also greater among 
spray irrigation workers compared to controls but the difference was not statistically 
significant (Table 2).  After adjusting for changes over time in addition to the other 
predictor variables using the GLMM, there were no significant differences in the odds 
of colonization with any of the bacteria of interest (p=0.7486) (data not shown). 
 
Factors impacting MSSA and VSE colonization among spray irrigation workers 
 The results of our logistic regression models focused only on spray irrigation 
workers showed that most of the variables used in our model did not have statistically 
significant effects on the odds of the spray irrigation workers being colonized with 
MSSA, MDR MSSA, VSE, or either MSSA or VSE (data not shown).  However, 
spray irrigation workers, who reported either personally having worked in a 
healthcare setting or having a household member who had worked in a healthcare 
setting (n=8) tended to be more likely to be colonized with either MSSA or VSE 
compared to those who did not report this type of exposure (OR=7.50; 95% CI 







MRSA and MSSA prevalence 
Based on the 2003–2004 National Health and Nutrition Examination Survey 
(NHANES), between 27.2% and 30% of the U.S. population were colonized with S. 
aureus (Gorwitz et al. 2008).  It has also been estimated that 20-30% of the general 
population is colonized in the nostrils with S. aureus (FDA 2009; John and Barg 
1999).  Twenty-eight percent of all study participants in this study were nasally 
colonized with MSSA, which falls within the expected range of MSSA prevalence.  
Previous studies have identified low carriage rates of MRSA in the community, 
including a study by Gorwitz et al. (2008) that found that the prevalence of MRSA 
colonization in the U.S. is approximately 1.5% based on the 2003-2004 NHANES 
data (Gorwitz et al. 2008).  Therefore, the finding that MRSA was not detected in any 
samples in the current study could be a factor of our small sample size.  Also, the lack 
of any statistically significant difference in the odds of MSSA colonization between 
spray irrigation workers and office worker controls could also be due to our small 
sample size.  To be able to detect a 1.5 difference in the odds of MSSA colonization 
between spray irrigation workers and controls with 80% power, we would have 
needed to enroll approximately 878 participants.  Our experience, and the anecdotal 
experience of others, however, has shown that gaining access to wastewater reuse 
sites for research purposes is difficult, limiting the number of possible study 






VRE and VSE prevalence 
Community-associated VRE (CA-VRE) (defined as no previous hospital stay 
reported) is rarely reported in the U.S. (McDonald 1997; Stevenson 2005), however, 
the introduction of VRE into hospital settings from outside environments has been 
documented in both the U.S. and internationally (Anzar et al. 2004; Raja et al. 2005; 
Stevenson 2005).  In a study by Stevenson et al. (2005) of rural U.S. hospitals, 22% 
of patients with positive VRE cultures had been in the hospital for under 48 hr or 
were outpatients, prompting classification as a CA-VRE infection (Stevenson 2005).  
A 1999 study in Germany found a 0.9% prevalence of VRE among a “healthy” 
student population, not admitted to a hospital for infection with VRE (Wendt et al. 
1999).  Therefore, the fact that VRE was not detected in any of the current study’s 
participants could also be a factor of our small sample size.   
 
E. faecalis and E. faecium have previously been isolated in small numbers 
from the upper respiratory tract; however, in a large-scale hospital study of VRE and 
MRSA colonization by Warren et al. (2004), the majority of VRE-positive specimens 
were recovered from stool or rectal samples (87%) compared to respiratory (0%) and 
soft tissue and wound samples (2%) (PR Murray et al. 2002; Warren et al. 2004).  
Yet, in a study by Hendrix et al. (2001), 13% of all hospital patients who provided an 
oropharyngeal (back of the oral cavity) culture had VRE-positive results (Hendrix et 
al. 2001).  Rectal swabs are often used to detect VRE, however to increase 
participation among our study population we did not use this method.  Using only 





could have underestimated the true prevalence of VRE and VSE among the study 
population.  To have been able to detect a difference in the VSE colonization of our 
two groups with 80% power, we would have had to enroll 1,644 participants. 
 
Public health implications 
Although we found no statistically significant differences between the odds of 
reclaimed water spray irrigation workers and office worker controls being colonized 
with S. aureus or enterococci, results from previous studies from our research group 
that detected MRSA and VRE in wastewater intended for reuse raises potential public 
health concerns for those working with or otherwise exposed to reclaimed water 
(Rosenberg Goldstein et al. 2012).  Several previous studies have analyzed the risk of 
different types of infections among individuals occupationally, recreationally, or 
residentially exposed to wastewater that has undergone various levels of treatment 
and found conflicting results (Blumenthal et al. 2001; Devaux et al. 2001; Shuval 
1991).  A study in Mexican agricultural communities found increased odds of 
parasitic infections and associated diarrheal disease among individuals exposed to 
wastewater stored in one reservoir (which could be categorized as secondary 
(biologically) treated wastewater) and used for agricultural irrigation (Blumenthal et 
al. 2001).  With additional time or storage in more than one reservoir, there was no 
difference in the odds of infection between exposed and unexposed groups 
(Blumenthal et al. 2001).  Durand and Schwebach (1989) examined whether 
individuals recreationally exposed to turf irrigated with reclaimed water in Colorado 





irrigated with potable water (Durand and Schwebach 1989).  They found no 
difference in the number of reported illnesses between the exposed and unexposed 
groups.  However, their study did show that exposure to wet grass was associated 
with more reported GI symptoms (Durand and Schwebach 1989).  Because reclaimed 
water irrigation workers routinely work in wet grass as they are spraying, they could 
be at a greater risk for experiencing GI symptoms.  Similarly, a study by Devaux et 
al. (2001) in France identified that farmers exposed to wastewater treated in 
stabilization ponds reported more respiratory and GI symptoms compared to a non-
exposed group of controls (Devaux et al. 2001).  A Texas-based study found that 
individuals exposed to secondary treated wastewater reused for agricultural spray 
irrigation had an increased risk of viral infections 1.5-1.8 times that of individuals not 
exposed to reclaimed water (Camann et al. 1988). 
 
To our knowledge, the current study is the first to evaluate occupational 
exposure to S. aureus and enterococci in reclaimed water in the United States.  
Although the differences between odds of MSSA, MDR MSSA, and VSE 
colonization in this study were not statistically significant, the data still provide 
evidence of potential human health issues that should be further investigated with 
larger samples sizes across the U.S.  This is particularly important with regard to 
potential exposures to MRSA and VRE–leading causes of hospital-acquired 
infections, as well as microorganisms associated with a growing number of 
community-acquired infections–because it has been detected in treated U.S. 





Similarly, more work is needed to evaluate potential exposures to other human 
pathogens among spray irrigation workers including Legionella spp. and Aeromonas 
spp. since these microorganisms have also been isolated from reclaimed water 
(Brissaud et al. 2008; Jjemba et al. 2010; Palmer et al. 1995). 
 
Conclusions 
Our findings are the first to evaluate and detect MSSA and VSE among spray 
irrigation workers using reclaimed water.  As reclaimed water use continues to grow, 
additional studies with larger samples sizes are needed to further evaluate 
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Table 1: Comparison of participant characteristics between spray irrigation workers 
and office worker controls 
a
  
Variable n (%) p-value 





Age (years)   0.406 
≤ 17 3 (16) 0 (0)  
18-19 2 (11) 2 (8)  
20-30 4 (21) 10 (42)  
31-41 5 (26) 6 (25)  
42-56 4 (21) 5 (21)  
>56 1 (5) 1 (4)  
Gender   1.00 
Male 18 (95) 23 (96)  
Female 1 (5) 1 (4)  
Race   0.575 
Caucasian 17 (90) 23 (96)  
Other 2 (10) 1 (4)  
Education   < 0.001 
Less than high school 1 (5) 0 (0)  
High school 12 (63) 0 (0)  
Associate 2 (11) 0 (0)  
College 4 (21) 24 (100)  
Yearly income ($1000s)   0.011 
< 15 10 (56) 5 (21)  
15-25 3 (17) 6 (25)  
25-35 2 (11) 1 (4)  
35-50 2 (11) 1 (4)  
> 50 1 (6) 11 (46)  
Duration in job    0.221 





> 1 month – ≤ 6 months 6 (31.5) 3 (12.5)  
> 6 months – ≤ 2 years 3 (16) 5 (21)  
> 2 –  ≤ 5 years 5 (26) 5 (21)  
> 5 – ≤ 20 years 3 (16) 5 (21)  
≥ 20 years 0 (0) 5 (21)  
Currently smoke   0.002 
Yes  10 (53) 2 (8)  
No 9 (47) 22 (92)  
Smoke more than 100 
cigarettes in past 6 
months 
  <0.001 
Yes 9 (47) 0 (0)  
No 10 (53) 24 (100)  
Personally worked in 
healthcare setting 
  1.000 
Yes 3 (16) 4 (17)  
No 16 (84) 20 (83)  
Household  member 
worked in healthcare 
setting 
  0.686 
Yes 6 (32) 9 (37.5)  
No 13 (68) 15 (62.5)  
a
 Differences between spray irrigation workers and controls were analyzed using 
Fisher’s exact test for all analyses except “Household Member Worked in Healthcare 






Table 2: Estimated odds ratios of ever being colonized with MSSA, MDR MSSA, or 
either MSSA or VSE, by occupational status. 
 Unadjusted 
OR 




MSSA     
Spray irrigation 
worker 
0.87 0.23, 3.34 1.4 0.09, 22.4 
Office worker 
control 
—     









—    
MSSA or VSE     
Spray irrigation 
worker 
1.42 0.39, 5.11 2.55 0.15, 44.15 
Office worker 
control 
—    
a
 Confounders included in the adjusted model were: education, duration of job, yearly 







Figure 1: Prevalence of methicillin-resistant Staphylococcus aureus (MRSA), 
methicillin-susceptible S. aureus (MSSA), multidrug-resistant (MDR) MSSA, 
vancomycin-resistant enterococci (VRE), vancomycin-susceptible enterococci (VSE), 




 No MRSA was detected in any samples. 
b






Figure 2: Percent resistance to antimicrobial agents observed among MSSA isolates 
recovered from spray irrigation worker and office worker control nasal and dermal 
swabs.  ERY= erythromycin; CLI=clindamycin; SYN=quinupristin/dalfopristin; 
DAP=daptomycin; VAN=vancomycin; TET=tetracycline; AMP=ampicillin; 
GEN=gentamicin; LEVO=levofloxacin; LZD=linezolid (LZD;0.5–8 μg/mL), 
AXO=ceftriaxone; STR=streptomycin; PEN=penicillin; RIF=rifampin; 









Appendix A  
Antimicrobial Susceptibility Testing Detailed Methods 
The following methods were used to perform antimicrobial susceptibility 
testing on all PCR-confirmed S. aureus (n=97) and Enterococcus spp. (n=20) isolates 
using the Sensititre® microbroth dilution system (Trek Diagnostic Systems Inc., 
Cleveland, OH) in accordance with the manufacturer’s instructions.  Overnight 
cultures were transferred to sterile demineralized water (Trek Diagnostic Systems) to 
achieve a 0.5 McFarland standard. Then, 30 μL of the suspension  for S. aureus and 
50 μL of the suspension for enterococci was transferred to sterile cation-adjusted 
Mueller Hinton broth (Trek Diagnostic Systems), and 50 μL of the broth solution was 
then dispensed into GPN3F minimal inhibitory concentration (MIC) plates (Trek 
Diagnostic Systems Inc.) with the following antibiotics: erythromycin (ERY; 0.25–
4μg/mL), clindamycin (CLI;0.12–2μg/mL), quinupristin/dalfopristin (SYN; 0.12–4 
μg/mL), daptomycin (DAP;0.25–8 μg/mL), vancomycin (VAN; 1–128 μg/mL), 
tetracycline (TET; 2–16μg/mL), ampicillin (AMP; 0.12–16μg/mL), gentamicin 
(GEN; 2–16, 500 μg/mL), levofloxacin (LEVO; 0.25–8 μg/mL), linezolid (LZD;0.5–
8 μg/mL), ceftriaxone (AXO; 8–64 μg/mL), streptomycin (STR; 1,000 μg/mL), 
penicillin (PEN; 0.06–8 μg/mL), rifampin (RIF; 0.5–4 μg/mL), gatifloxacin (GAT;1–
8 μg/mL), ciprofloxacin (CIP; 0.5–2 μg/mL), trimethoprim/sulfamethoxazole (SXT; 
1/19–4/76 μg/mL), and oxacillin+2%NaCl (OXA+;0.25–8 μg/mL). Plates were 














Chapter 6:  Conclusions & Public Health Significance 
 
The need for alternative water sources because of increased freshwater 
demand combined with increased water shortages has spurred the growth of 
reclaimed water applications in the United States.  Although around 2.22 billion 
gallons of reclaimed water are being used in the U.S. per day, there are no federal 
regulations governing the treatment or use of reclaimed water (Miller 2011).  EPA 
has recently updated their Guidelines for Water Reuse, but each state determines 
whether or not to adopt water reuse regulations or guidelines (EPA 2012).  
 
There are a wide range of permitted uses for reclaimed water among different 
U.S. states (EPA 2012).  State oversight of wastewater reuse has created a patchwork 
of rules that could have unintended consequences for the health of certain states’ 
populations if they are exposed to reclaimed water that contains microbial or 
chemical contaminants not removed by wastewater treatment (EPA 2012; NRC 2012; 
WHO 2006).  Although antibiotic-resistant bacterial infections are a growing public 
health problem, little research has been conducted into the presence of, and exposure 
to, antibiotic-resistant bacteria in reclaimed water.  According to EPA’s 2012 
Guidelines, “Where reclaimed water is intended for nonpotable reuse, the major 
priority in design, construction, and operation of a reclaimed water distribution 
system is the prevention of cross-connections [,]” not water quality (EPA 2012).  





reclaimed water contamination, human exposure to nonpotable reclaimed water in 
planned applications could also have health consequences from inhalation or dermal 
exposure, or even inadvertent ingestion from hand-to-mouth behavior. 
It is not logistically or economically feasible to routinely monitor wastewater 
or reclaimed water for all possible contaminants that could impact human health.  
However, the public health and water reuse communities have a responsibility to fully 
explore contaminants known to be contained in human waste and wastewater that 
could cause serious human health consequences.  The 2012 EPA Guidelines for 
Water Reuse suggest total or fecal coliforms, both indicator organisms, as the only 
microorganisms to monitor for reuse applications (EPA 2012).  However, numerous 
studies have identified a weak correlation between any single indicator organism and 
most human pathogens (Harwood et al. 2005; Jjemba et al. 2010).  
 
My dissertation research focused on examining the public health risks of 
antibiotic- resistant bacteria surviving wastewater treatment and causing exposure 
during water reuse applications.  The first two articles of this dissertation explored 
whether or not two of the leading causes of antibiotic-resistant bacterial infections, 
MRSA and VRE, could survive the wastewater treatment process.  MRSA and VRE 
were detected at all WWTPs sampled as part of this dissertation research.  The 
percentage of MRSA-positive samples and concentration of VRE decreased as 
treatment progressed at all WWTPs.  Neither MRSA nor VRE were ever identified in 
tertiary-treated (chlorinated) samples, but both were identified in an effluent sample 





(secondary-treated effluent).  Secondary treatment is the highest level of wastewater 
treatment required in the U.S.  In addition to identifying the mere presence of MRSA 
and VRE in wastewater, the majority of both MRSA and VRE isolates (93% and 
100%, respectively) were multidrug resistant (MDR), resistant to two or more classes 
of clinically relevant antibiotics tested.  These results could have major public health 
implications for WWTP workers in the U.S. as well as those at water reuse sites if 
these organisms, and other human pathogens, survive the distribution process and any 
further treatment at reuse sites.  MDR bacteria limit treatment options for those 
infected with this type of bacteria.  This was the first report of MRSA at U.S. 
WWTPs and the first report of VRE at WWTPs that discharge effluent intended for 
reuse and at Mid-Atlantic WWTPs. 
 
Although I did detect MRSA and VRE in at least one sample from each 
WWTP sampled for this dissertation research, I could have underestimated the true 
prevalence of these organisms by relying on culture-based detection techniques as 
only 1% of bacteria are culturable.  To provide a more accurate estimation of MRSA 
and VRE in U.S. wastewater, it would be important for future studies to pair culture-
based techniques with molecular techniques to detect organism- and antibiotic-
resistance-specific genes.  I could have also used metagenomics to explore the 
bacterial diversity of wastewater samples in addition to evaluating the presence of 






While the first portion of this dissertation explored the presence of MRSA and 
VRE in wastewater and antibiotic resistance patterns among isolates, the second 
portion of this research evaluated potential human exposure to MRSA and VRE in 
reclaimed water.  Although irrigation with reclaimed water is growing, limited data 
exists on pathogens present in reclaimed water, as well as health risks from exposure 
to this water source (Blumenthal et al. 2001; Devaux et al. 2001; Durand and 
Schwebach 1989; Harwood et al. 2005; Jjemba et al. 2010).   Several previous studies 
have analyzed the risk of different types of infections among individuals 
occupationally, recreationally, or residentially exposed to wastewater that has 
undergone various levels of treatment and found conflicting results (Blumenthal et al. 
2001; Devaux et al. 2001; Shuval 1991).  In two separate studies, one in Mexico and 
one in the U.S., the risk of parasitic and viral infections were found to be greater 
among individuals exposed to secondary treated wastewater than controls 
(Blumenthal et al. 2001; Camann et al. 1988).  When considering reported symptoms, 
a study of those recreationally exposed to turf irrigated with reclaimed water in 
Colorado found no difference in the number of reported illnesses between the 
exposed and unexposed groups (Durand and Schwebach 1989).  However, this study 
did show that exposure to wet grass was associated with more reported GI symptoms 
(Durand and Schwebach 1989).  Because reclaimed water irrigation workers routinely 
work in wet grass as they are spraying, they could be at a greater risk for experiencing 
GI symptoms.  Similarly, a study by Devaux et al. (2001) in France identified that 
farmers exposed to wastewater treated in stabilization ponds reported more 





et al. 2001).  However, no published studies have ever evaluated the risk for 
occupational exposure to antibiotic-resistant bacteria from reclaimed water. 
 
To address this lack of exposure data, in the third article included in this 
dissertation, I collected nasal and dermal swabs from 19 reclaimed water spray 
irrigation workers and 24 office worker controls and analyzed them for MRSA, 
MSSA, VRE, and VSE and compared the odds of colonization with these four 
bacteria between the spray irrigators and controls.  MRSA and VRE were not 
detected in any nasal or dermal swab samples from reclaimed water spray irrigation 
workers or controls.  MSSA was detected in 26% and 29% of spray irrigation workers 
and controls, respectively. VSE was detected in 11% and 0% of spray irrigation 
workers and controls, respectively.  The odds of MSSA, MDR MSSA, and either 
MSSA or VSE colonization were not significantly different between spray irrigators 
and controls.  Although our findings were not statistically significant, which could be 
a factor of our limited study population size, our findings are still important because 
they begin to fill in a knowledge gap about public health implications from 
occupational exposure to reclaimed water.  Because individuals are also 
recreationally and residentially exposed to reclaimed water, future research should 
also evaluate MRSA, MSSA, VRE, and VSE colonization among individuals living 
in proximity to reuse sites with varying levels of treated wastewater. 
 
Also, more work is needed to evaluate potential exposures to other human 





Aeromonas spp. since these microorganisms have previously been isolated from 
reclaimed water (Brissaud et al. 2008; Jjemba et al. 2010; Palmer et al. 1995).  As 
with the wastewater samples, to be able to better capture bacterial diversity in the 
nasal and dermal microbiomes of individuals occupationally exposed to reclaimed 
water, metagenomics could be included in future studies. 
 
In summary, this dissertation research provides additional scientific evidence 
that antibiotic-resistant bacteria can survive secondary wastewater treatment and 
might cause an increased risk of infection among individuals exposed to reclaimed 
water.  These findings can be used to support environmental and public health policy 
efforts to safely use reclaimed water in the United States.  Ideally these findings 
would also help bolster efforts to curb the over-prescription and misuse of 
antimicrobials among humans and animals, in agriculture, and in personal care 
products.  However because of the widescale and multi-industry nature of this issue, 
it is important to also consider alternative, more immediate, ways to reduce human 
exposure to pathogens that may remain in wastewater and reclaimed water through 
means such as health education, engineering controls, and the use of personal 
protective equipment. 
 
 Health education and specifically hygiene promotion have been suggested as 
important paths to explore to protect the health of those occupationally exposed to 
reclaimed water (Blumenthal et al. 2000).  In the past decade there have been 





healthcare workers.  Previous studies have found that factors such as perceived ability 
and attitude about health behavior are more reactive to program design and promotion 
than demographic variables which have been the focus of traditional education 
campaigns (Apodaca et al. 1997).  Whitby and McLaws (2007) emphasized the 
behavioral components of handwashing and proposed that the impact of the physical 
environment and perceptions of the environment are less important than traditionally 
thought (Whitby and McLaws 2007).  In a study by Vernon et al. (2003), it was also 
concluded that the sink-to-bed ratio was not significantly associated with observed 
adherence to handwashing among healthcare workers (Vernon et al. 2003). Vernon 
hypothesized that other determinants, namely lack of time and physical damage to 
skin, are better predictors of healthcare workers’ actual hand washing behavior 
(Vernon, 2003).  Vernon asserted that the perception of large amounts of time 
required to wash hands, a behavioral belief, could be reduced with the introduction of 
alcohol-based hand sanitizers.   
 
However, based on Whitby and McLaw’s (2007) research, unless an 
individual perceives contact as presenting a risk to him or herself, s/he will not feel 
that it is important to wash his/her hands at all, whether it is time efficient or not 
(Whitby and McLaws 2007).  Therefore a combination of educational and practical 
interventions might be needed, such as emphasizing the personal risk for infection as 
well as making handwashing and personal protective equipment available.  A VRE 





the use of interventions that included both the use of waterless disinfectants for 
handwashing and mandatory in-service education (Sherer 2005).    
 
In addition to education, the use of engineering controls could reduce 
exposure to contaminants in reclaimed water.  In Australia, some states have a four 
hour “withholding period” between reclaimed water application and use to reduce 
exposure to contaminants potentially contained in the water (O'Toole et al. 2008).  A 
study by O’Toole et al. (2008) found that levels of E. coli were significantly reduced 
after the four hour period and suggested that risk of enteric bacterial infections could 
be reduced with withholding periods (O'Toole et al. 2008).  However, for reclaimed 
water spray irrigators, this type of withholding period might not be feasible. 
 
Wearing personal protective equipment (PPE) could be another possible 
control to reduce occupational exposure to pathogens in reclaimed water among spray 
irrigation workers.  Blumenthal et al. (2000) suggested that the use of protective 
equipment including footwear for farmers and gloves for crop handlers working with 
reclaimed water could effectively reduce exposures to contaminants contained in the 
water (Blumenthal et al. 2000).  In a study by Weldon et al. (2000) among WWTP 
workers, never wearing face protection was significantly associated with hepatitis A 
colonization (Weldon et al. 2000).  Similarly, in a study of hog producers, a smaller 
percentage of workers who wore N95 masks during work activities (40%) were 
colonized with human pathogens or positive for tetracycline-resistance genes 






Leedom Larson et al. (2012) explored a multipronged approach for 
interventions to reduce MRSA colonization among pork producers; their suggestions 
are outlined in Table 1 below (Leedom Larson et al. 2012).  The authors found that 
seven pork production shower facilities that had previously tested positive for MRSA 
had no detectable MRSA after implementation of the interventions listed in Table 1 
(Leedom Larson et al. 2012).  However, they also found that four previously MRSA-
free shower facilities were positive for MRSA after the intervention (Leedom Larson 
et al. 2012).  They suggested that the interventions used in their study could have 
been improved with more clearly worded instructions (Leedom Larson et al. 2012).  
Using the interventions suggested by Leedom Larson et al. (2012) as a basis for 
interventions with reclaimed water spray irrigation workers, with an emphasis on 







Table 1. Adapted methods to prevent MRSA infection to pork producers. Source: 
Leedom Larson et al., 2012. 
 Category Methods 
Hygiene Educate employees about good hand hygiene. 
 
Encourage use of alcohol-based hand sanitizers when 
hands not visibly dirty. 
 
Educate employees about general infection control. 
  Educate employees about MRSA transmission. 
Wounds Report cuts or wounds to supervisor immediately. 
 
Clean wounds or abrasions immediately and cover with a 
clean, dry bandage. 
 
Restrict worker to a single shower stall and disinfect after 
each use if wound cannot be covered. 
  
Encourage proper treatment of non-healing wounds by a 
healthcare professional. 
Showers Advise workers to use warm water and soap. 
 
Use liquid soap dispensers instead of bar soap. 
 
Provide separate, clean towels for each employee. 
  
Discourage sharing of personal items including soap and 
razors. 
Clothing and 
laundry Provide separate boots for each worker. 
 
Provide separate, clean coveralls for each worker. 
 
Wash soiled coveralls separately from other clothing and 
towels. 
 
Wash all coveralls, clothing (including underwear and 
socks), and towels with hot water and soap after each use. 
  
Machine dry every article of clothing and towel after 
washing. 
Environment 
Develop a protocol for cleaning and disinfection of 
showers. 
 
Include removal of visible dirt, proper dilution of 
disinfectant, and contact time. 
 
Use dilute bleach (1/4 cup bleach in 1 gal water) or EPA-
approved disinfectant. 
 
Develop a routine schedule for cleaning and disinfection 
of showers. 







Reclaimed water might very well be a safe alternative water source, but it is 
important to evaluate the human health risks associated with its use to be able to 
identify areas for improvement in terms of treatment and application, and to inform 
related policy.  Also, although alternative sources of freshwater are becoming a 
necessity because of current demand and dwindling supplies, the focus should not 
exclusively be on harvesting new sources of water, but instead include encouraging 
water efficiency and conservation of available water resources.  Until we better 
understand the types of pathogens that remain in treated wastewater and the health 
risks from exposure to reclaimed water, we cannot improve its use.  It is my hope that 
the results of this dissertation research will be able to encourage additional research 
and help inform decision makers about possible human health risks when crafting 
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University of Maryland Bioscience & Technology Review Day Family, Community and 
Public Health Poster Winner (November 2012) 
• Poster presentation “Analysis of Private Well Water Quality and Well Owner 
Education Program in Maryland: A Pilot Project.” 
 
“Engaged Me” Award, Priester National Extension Health Conference (April 2012) 
• Oral presentation, “Well Water Education Program: A Collaborative Project 
Between Extension Educators and University of Maryland Public Health 
Researchers.” 
 
Student Scholarship, Priester National Extension Health Conference (April 2012) 
 
Maryland Institute for Applied Environmental Health Fellowship (November 2011 – 
Present) 
 
University of Maryland Bioscience & Technology Review Day Water Quality and 
Management Poster Winner (November 2011) 
• Poster presentation “Survival of Methicillin-resistant Staphylococcus aureus in 
Secondary Treated Wastewater.” 
 
APHA Environment Section Student Scholarship (October 2011) 
 
University of Maryland, College Park School of Public Health, Student Research 
Interaction Day Poster Award (September 2011) 
 
University of Maryland Graduate Research Interaction Day Health Presentation Award 
(2
nd
 place) (April 2011) 
• Oral presentation, “Survival of Methicillin-resistant Staphylococcus aureus in 
Secondary Treated Wastewater.”  
 
University of Maryland Graduate Student Summer Research Fellowship (Fall 2010 – 
Present) 
 
Dean’s Fellowship (Fall 2010 – Present) 
 
Maryland Water Resources Research Center 2010 Summer Fellowship (May-August, 
2010) 
 
Dean’s Graduate Scholar (March 2010) 
 
University of Maryland Bioscience & Technology Review Day Family, Community and 
Public Health Poster Award (November 2009) 
• Poster titled “Irrigation workers’ exposures to antimicrobial-resistant bacteria and 
antimicrobials present in reclaimed wastewater." 
 
American Public Health Association Environment Section's Student Achievement  
Poster Award (November 2009) 
• Poster titled “Irrigation workers’ exposures to antimicrobial-resistant bacteria and 






Jacob K. Goldhaber Travel Grant (August 2009) 
 
SERVICE 
“Climbing Up and Reaching Back (CURB)”: Ladder of Support for Research Careers 
in Biomedical and Behavioral Research, College Park, MD 
Graduate Student Presenter (December 2011 – April 2012) 
• Prepared and presented lecture and interactive experience related to environmental 
health for high school students. 
 
Delta Omega, Gamma Zeta Chapter, College Park, MD 
Inaugural President, (November 2011 – September 2012) 
• Coordinated meetings, service activities, nomination process, and induction 
ceremony. 
 
Public Health Garden, College Park, MD 
Co-founder and Secretary Treasurer (January 2011 – June 2012) 
• Developed constitution for club and collaborated with stakeholders on campus to 
establish an edible garden. 
 
Dean’s Student Advisory Committee, University of Maryland School of Public Health  
Student Representative for Maryland Institute for Applied Environmental Health (October 
2009-May 2012) 
•  Proposed Public Health Garden idea.  
•  Provided feedback to Dean of School of Public Health on School and University 
issues. 
 
Accreditation Committee, University of Maryland School of Public Health 
Student Representative for Maryland Institute for Applied Environmental Health (August – 
October 2009) 
•   Represented the Institute and the School during the site visit for the accreditation 
of the School of Public Health by the Council on Education for Public Health 
(CEPH). 
 
United Nations Commission on Sustainable Development (CSD-16), New York, NY  
Youth Delegate, (May 2008) 
• Drafted policy documents, participated in meetings, and presented action items on 




American Public Health Association 
American Society for Microbiology 
American Water Resources Association 
American Water Works Association 
Delta Omega 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
